| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP6V1C1 KIF1A MYH7B VPS4A VPS4B ACSS1 ABCC9 CHD2 RFC1 ABCA10 ACSM4 DDX23 ABCD1 KIF13A DDX39A DDX39B TOP2A ATP5F1A DYNC1H1 CDK7 | 9.87e-11 | 614 | 108 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF1A VPS4A VPS4B ABCC9 CHD2 RFC1 ABCA10 DDX23 ABCD1 KIF13A DDX39A DDX39B ATP5F1A DYNC1H1 | 1.13e-07 | 441 | 108 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF1A VPS4A VPS4B ABCC9 CHD2 RFC1 ABCA10 DDX23 ABCD1 KIF13A DDX39A RAB29 DDX39B ATP5F1A DYNC1H1 | 1.82e-05 | 775 | 108 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | glucosamine-6-phosphate deaminase activity | 2.90e-05 | 2 | 108 | 2 | GO:0004342 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | KIF1A VPS4A VPS4B ABCC9 CHD2 RFC1 ABCA10 DDX23 ABCD1 KIF13A DDX39A RAB29 DDX39B ATP5F1A DYNC1H1 | 4.54e-05 | 839 | 108 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KIF1A VPS4A VPS4B ABCC9 CHD2 RFC1 ABCA10 DDX23 ABCD1 KIF13A DDX39A RAB29 DDX39B ATP5F1A DYNC1H1 | 4.60e-05 | 840 | 108 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KIF1A VPS4A VPS4B ABCC9 CHD2 RFC1 ABCA10 DDX23 ABCD1 KIF13A DDX39A RAB29 DDX39B ATP5F1A DYNC1H1 | 4.60e-05 | 840 | 108 | 15 | GO:0016818 |
| GeneOntologyMolecularFunction | isomerase activity | 6.21e-04 | 192 | 108 | 6 | GO:0016853 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | ADCY10 GNPDA1 ACLY ACSS1 GART ABCC9 HMGCL NDUFS1 AK3 ACSM4 GNPDA2 MDH1B PGLS ACAA2 KHK ABCD1 ATP5F1A PMM1 | 9.14e-08 | 767 | 108 | 18 | GO:0055086 |
| GeneOntologyBiologicalProcess | purine nucleotide metabolic process | ADCY10 ACLY ACSS1 GART ABCC9 HMGCL NDUFS1 AK3 ACSM4 MDH1B PGLS ACAA2 KHK ABCD1 ATP5F1A | 8.10e-07 | 619 | 108 | 15 | GO:0006163 |
| GeneOntologyBiologicalProcess | purine-containing compound metabolic process | ADCY10 ACLY ACSS1 GART ABCC9 HMGCL NDUFS1 AK3 ACSM4 MDH1B PGLS ACAA2 KHK ABCD1 ATP5F1A | 1.54e-06 | 652 | 108 | 15 | GO:0072521 |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | ADCY10 ACLY ACSS1 GART ABCC9 HMGCL NDUFS1 AK3 ACSM4 MDH1B PGLS ACAA2 KHK ABCD1 ATP5F1A | 2.78e-06 | 684 | 108 | 15 | GO:0009117 |
| GeneOntologyBiologicalProcess | purine ribonucleotide metabolic process | ADCY10 ACLY ACSS1 GART ABCC9 HMGCL NDUFS1 AK3 ACSM4 ACAA2 KHK ABCD1 ATP5F1A | 2.80e-06 | 512 | 108 | 13 | GO:0009150 |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | ADCY10 ACLY ACSS1 GART ABCC9 HMGCL NDUFS1 AK3 ACSM4 MDH1B PGLS ACAA2 KHK ABCD1 ATP5F1A | 3.15e-06 | 691 | 108 | 15 | GO:0006753 |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | ADCY10 ACLY ACSS1 GART ABCC9 HMGCL NDUFS1 AK3 ACSM4 ACAA2 KHK ABCD1 ATP5F1A | 4.34e-06 | 533 | 108 | 13 | GO:0009259 |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | ADCY10 ACLY ACSS1 GART ABCC9 HMGCL NDUFS1 AK3 ACSM4 ACAA2 KHK ABCD1 ATP5F1A | 5.00e-06 | 540 | 108 | 13 | GO:0019693 |
| GeneOntologyBiologicalProcess | nuclear membrane organization | 5.13e-06 | 48 | 108 | 5 | GO:0071763 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 1.08e-05 | 144 | 108 | 7 | GO:0051261 | |
| GeneOntologyBiologicalProcess | nuclear envelope organization | 1.98e-05 | 63 | 108 | 5 | GO:0006998 | |
| GeneOntologyBiologicalProcess | metaphase chromosome alignment | 2.11e-05 | 107 | 108 | 6 | GO:0051310 | |
| GeneOntologyBiologicalProcess | generation of precursor metabolites and energy | ADCY10 GNPDA1 ACLY ABCC9 HMGCL NDUFS1 MDH1B PGLS KHK ABCD1 CDK1 ATP5F1A | 2.13e-05 | 529 | 108 | 12 | GO:0006091 |
| GeneOntologyBiologicalProcess | acyl-CoA metabolic process | 2.34e-05 | 109 | 108 | 6 | GO:0006637 | |
| GeneOntologyBiologicalProcess | thioester metabolic process | 2.34e-05 | 109 | 108 | 6 | GO:0035383 | |
| GeneOntologyBiologicalProcess | late endosome to lysosome transport via multivesicular body sorting pathway | 2.72e-05 | 2 | 108 | 2 | GO:0061764 | |
| GeneOntologyBiologicalProcess | glucosamine catabolic process | 2.72e-05 | 2 | 108 | 2 | GO:0006043 | |
| GeneOntologyBiologicalProcess | establishment of organelle localization | KIF1A MAP1B CENPF VPS4A VPS4B SHROOM2 NSFL1C CDK1 PLK1 KIF13A DYNC1H1 KPNB1 | 2.91e-05 | 546 | 108 | 12 | GO:0051656 |
| GeneOntologyBiologicalProcess | establishment of chromosome localization | 4.43e-05 | 122 | 108 | 6 | GO:0051303 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization involved in mitosis | 5.80e-05 | 187 | 108 | 7 | GO:1902850 | |
| GeneOntologyBiologicalProcess | chromosome localization | 6.32e-05 | 130 | 108 | 6 | GO:0050000 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | ADCY10 GNPDA1 MAN1A1 ACLY ACSS1 GART ABCC9 HMGCL NDUFS1 AK3 ACSM4 GNPDA2 PGLS ACAA2 KHK ABCD1 ATP5F1A PMM1 | 6.43e-05 | 1226 | 108 | 18 | GO:1901135 |
| GeneOntologyBiologicalProcess | cell division | CENPF VPS4A VPS4B CKAP5 PTN DCLRE1A CDK1 PLK1 KIF13A TOP2A DYNC1H1 SON CDK7 | 7.22e-05 | 697 | 108 | 13 | GO:0051301 |
| GeneOntologyBiologicalProcess | small molecule catabolic process | ADCY10 GNPDA1 GLS2 HMGCL CRYM GNPDA2 ACAA2 KHK HSD17B10 ABCD1 | 7.36e-05 | 421 | 108 | 10 | GO:0044282 |
| GeneOntologyBiologicalProcess | N-acetylglucosamine catabolic process | 8.12e-05 | 3 | 108 | 2 | GO:0006046 | |
| GeneOntologyBiologicalProcess | late endosomal microautophagy | 8.12e-05 | 3 | 108 | 2 | GO:0061738 | |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | ADCY10 GNPDA1 PLAAT4 ACLY ACSS1 GART ABCC9 HMGCL NDUFS1 AK3 ACSM4 MDH1B PGLS ACAA2 KHK ABCD1 ATP5F1A | 8.90e-05 | 1142 | 108 | 17 | GO:0019637 |
| GeneOntologyBiologicalProcess | organic acid catabolic process | 9.31e-05 | 272 | 108 | 8 | GO:0016054 | |
| GeneOntologyBiologicalProcess | carboxylic acid catabolic process | 9.31e-05 | 272 | 108 | 8 | GO:0046395 | |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate metabolic process | 1.03e-04 | 142 | 108 | 6 | GO:0033865 | |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate metabolic process | 1.03e-04 | 142 | 108 | 6 | GO:0033875 | |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate metabolic process | 1.03e-04 | 142 | 108 | 6 | GO:0034032 | |
| GeneOntologyBiologicalProcess | energy derivation by oxidation of organic compounds | 1.93e-04 | 385 | 108 | 9 | GO:0015980 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide biosynthetic process | 2.21e-04 | 232 | 108 | 7 | GO:0009152 | |
| GeneOntologyBiologicalProcess | nucleotide-sugar biosynthetic process | 2.29e-04 | 23 | 108 | 3 | GO:0009226 | |
| GeneOntologyBiologicalProcess | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway | 2.69e-04 | 5 | 108 | 2 | GO:0090611 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ADCY10 NEDD4L KIF1A MAP1B LAMA2 TWF2 TTC3 PREX2 PTN NTN4 BCL11B CSF1R EGFR | 2.88e-04 | 802 | 108 | 13 | GO:0048812 |
| GeneOntologyBiologicalProcess | organelle localization | KIF1A MAP1B CENPF VPS4A VPS4B SHROOM2 NSFL1C CDK1 PLK1 KIF13A DYNC1H1 KPNB1 | 3.14e-04 | 703 | 108 | 12 | GO:0051640 |
| GeneOntologyBiologicalProcess | establishment of spindle localization | 3.14e-04 | 62 | 108 | 4 | GO:0051293 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | GNPDA1 GLS2 ACLY ACSS1 GART ABCC9 HMGCL CRYM ACSM4 GNPDA2 MDH1B ACAA2 KHK HSD17B10 ABCD1 | 3.20e-04 | 1035 | 108 | 15 | GO:0019752 |
| GeneOntologyBiologicalProcess | ribonucleotide biosynthetic process | 3.24e-04 | 247 | 108 | 7 | GO:0009260 | |
| GeneOntologyBiologicalProcess | nuclear membrane reassembly | 3.32e-04 | 26 | 108 | 3 | GO:0031468 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ADCY10 NEDD4L KIF1A MAP1B LAMA2 TWF2 TTC3 PREX2 PTN NTN4 BCL11B CSF1R EGFR | 3.52e-04 | 819 | 108 | 13 | GO:0120039 |
| GeneOntologyBiologicalProcess | regulation of G2/M transition of mitotic cell cycle | 3.63e-04 | 116 | 108 | 5 | GO:0010389 | |
| GeneOntologyBiologicalProcess | ribose phosphate biosynthetic process | 3.74e-04 | 253 | 108 | 7 | GO:0046390 | |
| GeneOntologyBiologicalProcess | mitotic metaphase chromosome alignment | 3.76e-04 | 65 | 108 | 4 | GO:0007080 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ADCY10 NEDD4L KIF1A MAP1B LAMA2 TWF2 TTC3 PREX2 PTN NTN4 BCL11B CSF1R EGFR | 3.81e-04 | 826 | 108 | 13 | GO:0048858 |
| GeneOntologyBiologicalProcess | sister chromatid segregation | 3.83e-04 | 254 | 108 | 7 | GO:0000819 | |
| GeneOntologyBiologicalProcess | cellular component disassembly | ADCY10 MAP1B VPS4A VPS4B CKAP5 TWF2 SHROOM2 ASPH CDK1 PLK1 TOP2A | 3.92e-04 | 617 | 108 | 11 | GO:0022411 |
| GeneOntologyBiologicalProcess | glucosamine metabolic process | 4.02e-04 | 6 | 108 | 2 | GO:0006041 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | GNPDA1 GLS2 ACLY ACSS1 GART ABCC9 HMGCL CRYM ACSM4 GNPDA2 MDH1B ACAA2 KHK HSD17B10 ABCD1 | 4.04e-04 | 1058 | 108 | 15 | GO:0043436 |
| GeneOntologyBiologicalProcess | spindle localization | 4.23e-04 | 67 | 108 | 4 | GO:0051653 | |
| GeneOntologyBiologicalProcess | organic acid metabolic process | GNPDA1 GLS2 ACLY ACSS1 GART ABCC9 HMGCL CRYM ACSM4 GNPDA2 MDH1B ACAA2 KHK HSD17B10 ABCD1 | 4.29e-04 | 1064 | 108 | 15 | GO:0006082 |
| GeneOntologyBiologicalProcess | cellular respiration | 5.16e-04 | 267 | 108 | 7 | GO:0045333 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | CENPF VPS4A VPS4B CKAP5 NSFL1C EGFR CDK1 CDC73 PLK1 DYNC1H1 SON KPNB1 CDK7 | 5.23e-04 | 854 | 108 | 13 | GO:1903047 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ADCY10 NEDD4L KIF1A MAP1B LAMA2 TWF2 TTC3 PREX2 PTN NTN4 BCL11B CSF1R | 5.47e-04 | 748 | 108 | 12 | GO:0048667 |
| GeneOntologyBiologicalProcess | N-acetylneuraminate catabolic process | 5.61e-04 | 7 | 108 | 2 | GO:0019262 | |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | 5.73e-04 | 356 | 108 | 8 | GO:0098813 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G2/M phase transition | 6.32e-04 | 131 | 108 | 5 | GO:1902749 | |
| GeneOntologyBiologicalProcess | purine nucleotide biosynthetic process | 6.84e-04 | 280 | 108 | 7 | GO:0006164 | |
| GeneOntologyBiologicalProcess | regulation of spindle assembly | 7.42e-04 | 34 | 108 | 3 | GO:0090169 | |
| GeneOntologyBiologicalProcess | mitotic nuclear membrane disassembly | 7.45e-04 | 8 | 108 | 2 | GO:0007077 | |
| GeneOntologyBiologicalProcess | female meiosis chromosome segregation | 7.45e-04 | 8 | 108 | 2 | GO:0016321 | |
| GeneOntologyBiologicalProcess | neuron projection extension | 7.78e-04 | 207 | 108 | 6 | GO:1990138 | |
| GeneOntologyBiologicalProcess | purine-containing compound biosynthetic process | 8.07e-04 | 288 | 108 | 7 | GO:0072522 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle phase transition | 8.54e-04 | 140 | 108 | 5 | GO:1901989 | |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | 8.57e-04 | 291 | 108 | 7 | GO:0032984 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid segregation | 8.80e-04 | 212 | 108 | 6 | GO:0000070 | |
| GeneOntologyBiologicalProcess | positive regulation of cell growth | 9.02e-04 | 213 | 108 | 6 | GO:0030307 | |
| GeneOntologyBiologicalProcess | aerobic respiration | 9.02e-04 | 213 | 108 | 6 | GO:0009060 | |
| GeneOntologyBiologicalProcess | glucosamine-containing compound catabolic process | 9.55e-04 | 9 | 108 | 2 | GO:1901072 | |
| GeneOntologyBiologicalProcess | UDP-N-acetylglucosamine biosynthetic process | 9.55e-04 | 9 | 108 | 2 | GO:0006048 | |
| GeneOntologyBiologicalProcess | developmental cell growth | 1.04e-03 | 301 | 108 | 7 | GO:0048588 | |
| GeneOntologyBiologicalProcess | melanosome organization | 1.11e-03 | 39 | 108 | 3 | GO:0032438 | |
| GeneOntologyBiologicalProcess | acetyl-CoA metabolic process | 1.11e-03 | 39 | 108 | 3 | GO:0006084 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle process | 1.17e-03 | 307 | 108 | 7 | GO:0090068 | |
| GeneOntologyBiologicalProcess | ESCRT III complex disassembly | 1.19e-03 | 10 | 108 | 2 | GO:1904903 | |
| GeneOntologyBiologicalProcess | ESCRT complex disassembly | 1.19e-03 | 10 | 108 | 2 | GO:1904896 | |
| GeneOntologyBiologicalProcess | mitotic spindle organization | 1.20e-03 | 151 | 108 | 5 | GO:0007052 | |
| GeneOntologyBiologicalProcess | pigment granule organization | 1.20e-03 | 40 | 108 | 3 | GO:0048753 | |
| GeneOntologyBiologicalProcess | G2/M transition of mitotic cell cycle | 1.23e-03 | 152 | 108 | 5 | GO:0000086 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle phase transition | 1.25e-03 | 402 | 108 | 8 | GO:1901990 | |
| GeneOntologyBiologicalProcess | mitotic nuclear division | 1.38e-03 | 316 | 108 | 7 | GO:0140014 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | ADCY10 NEDD4L KIF1A MAP1B LAMA2 TWF2 TTC3 SHROOM2 PREX2 PTN NTN4 BCL11B CSF1R EGFR CAP1 | 1.39e-03 | 1194 | 108 | 15 | GO:0000902 |
| GeneOntologyBiologicalProcess | amino sugar biosynthetic process | 1.45e-03 | 11 | 108 | 2 | GO:0046349 | |
| GeneOntologyBiologicalProcess | oxaloacetate metabolic process | 1.45e-03 | 11 | 108 | 2 | GO:0006107 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 1.45e-03 | 93 | 108 | 4 | GO:0086003 | |
| GeneOntologyBiologicalProcess | nucleotide biosynthetic process | 1.46e-03 | 319 | 108 | 7 | GO:0009165 | |
| GeneOntologyBiologicalProcess | amide metabolic process | 1.46e-03 | 511 | 108 | 9 | GO:0043603 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate biosynthetic process | 1.48e-03 | 320 | 108 | 7 | GO:1901293 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | CENPF VPS4A VPS4B CSF1R NSFL1C EGFR CDK1 CDC73 PLK1 KIF13A DYNC1H1 CDK7 | 1.57e-03 | 845 | 108 | 12 | GO:0010564 |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | 1.57e-03 | 516 | 108 | 9 | GO:1901987 | |
| GeneOntologyBiologicalProcess | mitotic cytokinesis | 1.57e-03 | 95 | 108 | 4 | GO:0000281 | |
| GeneOntologyBiologicalProcess | nucleotide-sugar metabolic process | 1.58e-03 | 44 | 108 | 3 | GO:0009225 | |
| GeneOntologyBiologicalProcess | regulation of mitotic spindle organization | 1.58e-03 | 44 | 108 | 3 | GO:0060236 | |
| GeneOntologyBiologicalProcess | establishment of mitotic spindle localization | 1.58e-03 | 44 | 108 | 3 | GO:0040001 | |
| GeneOntologyBiologicalProcess | positive regulation of developmental growth | 1.59e-03 | 238 | 108 | 6 | GO:0048639 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative biosynthetic process | ADCY10 GNPDA1 MAN1A1 ACLY ACSS1 GART NDUFS1 AK3 GNPDA2 ATP5F1A PMM1 | 1.65e-03 | 736 | 108 | 11 | GO:1901137 |
| GeneOntologyBiologicalProcess | centrosome cycle | 1.72e-03 | 164 | 108 | 5 | GO:0007098 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 2.00e-03 | 249 | 108 | 6 | GO:0015931 | |
| GeneOntologyCellularComponent | mitochondrial matrix | GLS2 MRPL12 ACSS1 HMGCL NDUFS1 AK3 ACSM4 MRPS23 ACAA2 HSD17B10 CDK1 ATP5F1A | 1.52e-05 | 523 | 107 | 12 | GO:0005759 |
| GeneOntologyCellularComponent | dendritic spine membrane | 1.01e-04 | 18 | 107 | 3 | GO:0032591 | |
| GeneOntologyCellularComponent | midbody | 1.47e-04 | 222 | 107 | 7 | GO:0030496 | |
| GeneOntologyCellularComponent | organelle envelope | MRPL12 CENPF VPS4A NOA1 VPS4B HMGCL PPP1R15A NDUFS1 SLC3A1 EGFR MRPS23 ACAA2 HSD17B10 ABCD1 QSOX2 ATP5F1A DYNC1H1 KPNB1 | 3.43e-04 | 1435 | 107 | 18 | GO:0031967 |
| GeneOntologyCellularComponent | spindle pole | 6.57e-04 | 205 | 107 | 6 | GO:0000922 | |
| Domain | P-loop_NTPase | ADCY10 KIF1A MYH7B VPS4A NOA1 VPS4B ABCC9 CHD2 RFC1 ABCA10 AK3 DDX23 ABCD1 KIF13A DDX39A RAB29 DDX39B ATP5F1A DYNC1H1 | 3.11e-07 | 848 | 107 | 19 | IPR027417 |
| Domain | Glc/Gal-6P_isomerase | 7.28e-07 | 4 | 107 | 3 | IPR006148 | |
| Domain | Glucosamine_iso | 7.28e-07 | 4 | 107 | 3 | PF01182 | |
| Domain | - | ADCY10 VPS4A NOA1 VPS4B ABCC9 CHD2 RFC1 ABCA10 AK3 DDX23 ABCD1 DDX39A RAB29 DDX39B ATP5F1A DYNC1H1 | 5.21e-06 | 746 | 107 | 16 | 3.40.50.300 |
| Domain | AAA | 1.92e-05 | 144 | 107 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 1.92e-05 | 144 | 107 | 7 | IPR003593 | |
| Domain | Glucosamine6P_isomerase_CS | 3.25e-05 | 2 | 107 | 2 | IPR018321 | |
| Domain | Glucosamine6P_isomerase | 3.25e-05 | 2 | 107 | 2 | IPR004547 | |
| Domain | GLC_GALNAC_ISOMERASE | 3.25e-05 | 2 | 107 | 2 | PS01161 | |
| Domain | Na/H_exchanger_3/5 | 3.25e-05 | 2 | 107 | 2 | IPR018410 | |
| Domain | Kinesin-like_KIF1-typ | 1.94e-04 | 4 | 107 | 2 | IPR022140 | |
| Domain | KIF1B | 1.94e-04 | 4 | 107 | 2 | PF12423 | |
| Domain | Kinesin_assoc | 4.80e-04 | 6 | 107 | 2 | PF16183 | |
| Domain | Kinesin-like | 4.80e-04 | 6 | 107 | 2 | IPR022164 | |
| Domain | Kinesin_assoc | 4.80e-04 | 6 | 107 | 2 | IPR032405 | |
| Domain | DUF3694 | 4.80e-04 | 6 | 107 | 2 | PF12473 | |
| Domain | HEAT_REPEAT | 6.98e-04 | 70 | 107 | 4 | PS50077 | |
| Domain | Vps4_C | 8.90e-04 | 8 | 107 | 2 | IPR015415 | |
| Domain | Vps4_C | 8.90e-04 | 8 | 107 | 2 | PF09336 | |
| Domain | NaH_exchanger | 1.14e-03 | 9 | 107 | 2 | IPR004709 | |
| Domain | Q_MOTIF | 1.23e-03 | 37 | 107 | 3 | PS51195 | |
| Domain | RNA_helicase_DEAD_Q_motif | 1.23e-03 | 37 | 107 | 3 | IPR014014 | |
| Domain | MIT | 1.42e-03 | 10 | 107 | 2 | SM00745 | |
| Domain | MIT | 1.42e-03 | 10 | 107 | 2 | PF04212 | |
| Domain | Cation/H_exchanger_CPA1 | 1.73e-03 | 11 | 107 | 2 | IPR018422 | |
| Domain | ABC_transporter_CS | 1.78e-03 | 42 | 107 | 3 | IPR017871 | |
| Domain | - | 2.43e-03 | 13 | 107 | 2 | 1.20.58.280 | |
| Domain | ABC_tran | 2.62e-03 | 48 | 107 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 2.62e-03 | 48 | 107 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 2.78e-03 | 49 | 107 | 3 | PS00211 | |
| Domain | MIT | 2.83e-03 | 14 | 107 | 2 | IPR007330 | |
| Domain | Na_H_Exchanger | 2.83e-03 | 14 | 107 | 2 | PF00999 | |
| Domain | Cation/H_exchanger | 2.83e-03 | 14 | 107 | 2 | IPR006153 | |
| Domain | ABC_transporter-like | 2.95e-03 | 50 | 107 | 3 | IPR003439 | |
| Domain | AAA | 3.30e-03 | 52 | 107 | 3 | PF00004 | |
| Domain | Helicase_C | 3.34e-03 | 107 | 107 | 4 | PF00271 | |
| Domain | HELICc | 3.34e-03 | 107 | 107 | 4 | SM00490 | |
| Domain | Helicase_C | 3.46e-03 | 108 | 107 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 3.57e-03 | 109 | 107 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 3.57e-03 | 109 | 107 | 4 | PS51192 | |
| Domain | DEXDc | 3.57e-03 | 109 | 107 | 4 | SM00487 | |
| Domain | ATPase_AAA_core | 3.67e-03 | 54 | 107 | 3 | IPR003959 | |
| Domain | Helicase_ATP-bd | 3.69e-03 | 110 | 107 | 4 | IPR014001 | |
| Domain | Laminin_N | 3.70e-03 | 16 | 107 | 2 | IPR008211 | |
| Domain | LamNT | 3.70e-03 | 16 | 107 | 2 | SM00136 | |
| Domain | LAMININ_NTER | 3.70e-03 | 16 | 107 | 2 | PS51117 | |
| Domain | Laminin_N | 3.70e-03 | 16 | 107 | 2 | PF00055 | |
| Domain | HEAT_type_2 | 4.18e-03 | 17 | 107 | 2 | IPR021133 | |
| Domain | AMP-bd_C | 4.18e-03 | 17 | 107 | 2 | IPR025110 | |
| Domain | AMP-binding_C | 4.18e-03 | 17 | 107 | 2 | PF13193 | |
| Domain | - | 4.69e-03 | 18 | 107 | 2 | 3.30.470.20 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MAP1B VPS4A ACLY GART CKAP5 GEMIN5 CHD2 RFC1 NDUFS1 NSFL1C MAP4K5 ASPH MRPS23 DDX23 ACAA2 MACROH2A2 CDK1 PLK1 DDX39A DDX39B TOP2A ATP5F1A DYNC1H1 CAP1 SON KPNB1 | 5.57e-14 | 1353 | 108 | 26 | 29467282 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KIF1A CENPF ZC3H15 VPS4A ACLY TM9SF3 GART CKAP5 GEMIN5 HMGCL RFC1 TTC3 NDUFS1 PDIA4 THADA RBM5 HSD17B10 CDK1 CDC73 DDX39B TOP2A ATP5F1A DYNC1H1 CAP1 KPNB1 | 1.37e-12 | 1425 | 108 | 25 | 30948266 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TCAF1 NEDD4L MRPL12 ZC3H15 ACLY GART CKAP5 GEMIN5 RFC1 EGFR ASPH MRPS23 PGLS DDX23 HSD17B10 CDK1 CDC73 DDX39B TOP2A ATP5F1A DYNC1H1 SON KPNB1 | 5.76e-11 | 1415 | 108 | 23 | 28515276 |
| Pubmed | KIF1A MAP1B CENPF ACLY GART CKAP5 GEMIN5 CHD2 RFC1 NDUFS1 PDIA4 DDX23 DYNC1H1 CAP1 SON KPNB1 | 2.05e-10 | 653 | 108 | 16 | 22586326 | |
| Pubmed | ACLY CKAP5 RBM42 RFC1 NDUFS1 COQ8A ASPH DDX23 ACAA2 HSD17B10 PLK1 TOP2A ATP5F1A DYNC1H1 KPNB1 | 2.33e-10 | 560 | 108 | 15 | 35241646 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NEDD4L MAP1B CENPF ACLY GART CKAP5 ZNF512B PDIA4 DDX23 MACROH2A2 HSD17B10 CDK1 HEATR5B DDX39B TOP2A ATP5F1A DYNC1H1 SON KPNB1 | 3.85e-10 | 1024 | 108 | 19 | 24711643 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | ATP6V1C1 ACLY ACSS1 TM9SF3 GART GEMIN5 CHD2 RFC1 NDUFS1 NSFL1C DDX23 HSD17B10 CDK1 PLK1 DDX39A DDX39B TOP2A ATP5F1A DYNC1H1 SON KPNB1 | 6.41e-10 | 1318 | 108 | 21 | 30463901 |
| Pubmed | MAP1B ZC3H15 ACLY TM9SF3 GART CKAP5 PDIA4 NSFL1C EGFR MAP4K5 HSD17B10 CDK1 ATP5F1A DYNC1H1 CAP1 KPNB1 | 6.60e-10 | 708 | 108 | 16 | 39231216 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MRPL12 CENPF NOA1 ACSS1 TM9SF3 TTC3 NDUFS1 AK3 ZNF512B PDIA4 THADA NSFL1C MRPS23 ACAA2 HSD17B10 R3HDM1 PLK1 RAB29 DDX39B TOP2A ATP5F1A SON | 1.05e-09 | 1496 | 108 | 22 | 32877691 |
| Pubmed | MRPL12 NOA1 VPS4B ACSS1 TM9SF3 NDUFS1 AK3 COQ8A MRPS23 ACAA2 HSD17B10 QSOX2 ATP5F1A | 1.17e-09 | 438 | 108 | 13 | 32628020 | |
| Pubmed | ZC3H15 ACLY TM9SF3 CKAP5 TWF2 RFC1 PDIA4 NSFL1C RBM5 DDX23 CDK1 CDC73 PLK1 DDX39A TOP2A DYNC1H1 CAP1 KPNB1 CDK7 | 1.31e-09 | 1103 | 108 | 19 | 34189442 | |
| Pubmed | MYH7B ACLY VPS4B TM9SF3 GART NDUFS1 PDIA4 PGLS HSD17B10 CDK1 HEATR5B DDX39A QSOX2 ATP5F1A DYNC1H1 TANGO6 KPNB1 | 1.90e-09 | 878 | 108 | 17 | 37223481 | |
| Pubmed | NEDD4L MRPL12 ZC3H15 ACLY NOA1 GART GEMIN5 RFC1 NDUFS1 PDIA4 EGFR ASPH MRPS23 CDK1 DDX39A QSOX2 ATP5F1A DYNC1H1 KPNB1 CDK7 | 3.03e-09 | 1297 | 108 | 20 | 33545068 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ZBTB38 NEDD4L MAP1B ZC3H15 RBM42 CHD2 USP9Y NDUFS1 ZNF512B MRPS23 RBM5 DDX23 MACROH2A2 DDX39A DDX39B DYNC1H1 SON KPNB1 | 6.45e-09 | 1082 | 108 | 18 | 38697112 |
| Pubmed | MAP1B MRPL12 VPS4B GART USP9Y NDUFS1 PDIA4 HSD17B10 CDK1 DDX39A DDX39B ATP5F1A DYNC1H1 SON KPNB1 | 7.71e-09 | 725 | 108 | 15 | 27025967 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | ZC3H15 NOA1 TWF2 HMGCL RFC1 TTC3 PDIA4 PTN CRYM NSFL1C MAP4K5 RBM5 HSD17B10 CDC73 PLK1 DDX39A TNS1 KPNB1 | 1.16e-08 | 1124 | 108 | 18 | 21900206 |
| Pubmed | ACLY GART CKAP5 GEMIN5 NDUFS1 COQ8A HSD17B10 CDK1 CDC73 DDX39B DYNC1H1 CAP1 SON KPNB1 | 1.22e-08 | 638 | 108 | 14 | 33239621 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MAP1B MYH7B VPS4A ACLY TM9SF3 NDUFS1 PDIA4 THADA EGFR TOP2A ATP5F1A DYNC1H1 CAP1 KPNB1 | 1.45e-08 | 647 | 108 | 14 | 26618866 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MAP1B MRPL12 VPS4A ACLY GART CKAP5 GEMIN5 RFC1 PDIA4 NSFL1C MRPS23 HSD17B10 CDK1 DDX39B ATP5F1A DYNC1H1 CAP1 KPNB1 | 1.62e-08 | 1149 | 108 | 18 | 35446349 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | ATP6V1C1 GNPDA1 MAN1A1 ACLY VPS4B SHROOM2 SLC3A1 CRYM SLC9A3 PGLS KHK CDK1 RAB29 ATP5F1A DYNC1H1 CAP1 KPNB1 | 1.64e-08 | 1016 | 108 | 17 | 19056867 |
| Pubmed | KIF1A MRPL12 ACLY GART NDUFS1 PDIA4 DDX23 MACROH2A2 HSD17B10 CDK1 DDX39B TOP2A DYNC1H1 CAP1 KPNB1 | 2.24e-08 | 786 | 108 | 15 | 29128334 | |
| Pubmed | GART AK3 PDIA4 COQ8A HSD17B10 CDK1 CDC73 DDX39B TOP2A ATP5F1A DYNC1H1 KPNB1 | 2.37e-08 | 463 | 108 | 12 | 34901782 | |
| Pubmed | ZC3H15 ACLY GART GEMIN5 PDIA4 ASPH MRPS23 PLK1 TOP2A ATP5F1A SON KPNB1 | 2.72e-08 | 469 | 108 | 12 | 37314180 | |
| Pubmed | MAP1B MRPL12 ZC3H15 ACLY GART CKAP5 RFC1 ASPH MRPS23 HSD17B10 CDK1 PLK1 ATP5F1A DYNC1H1 KPNB1 | 3.27e-08 | 809 | 108 | 15 | 32129710 | |
| Pubmed | ATP6V1C1 KIF1A MRPL12 ZC3H15 NOA1 TM9SF3 CKAP5 RBM42 GEMIN5 CHD2 NDUFS1 ASPH ARHGEF9 MRPS23 RBM5 HSD17B10 HEATR5B ATP5F1A SON CDK7 | 3.31e-08 | 1497 | 108 | 20 | 31527615 | |
| Pubmed | 4.09e-08 | 304 | 108 | 10 | 32235678 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | MAP1B CENPF MRPS23 PGLS ACAA2 CDK1 CDC73 PLK1 DDX39A DDX39B TOP2A ATP5F1A DYNC1H1 SON | 4.13e-08 | 704 | 108 | 14 | 29955894 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | TCAF1 VPS4A ACLY VPS4B TM9SF3 GART RFC1 NDUFS1 COQ8A DDX23 HSD17B10 CDK1 PLK1 DDX39A DDX39B ATP5F1A DYNC1H1 KPNB1 | 6.30e-08 | 1257 | 108 | 18 | 37317656 |
| Pubmed | KIF1A VPS4B TM9SF3 NDUFS1 EGFR COQ8A HSD17B10 PLK1 ATP5F1A KPNB1 | 7.20e-08 | 323 | 108 | 10 | 24797263 | |
| Pubmed | MRPL12 MYH7B ACSS1 LAMA2 NDUFS1 ACAA2 HSD17B10 ATP5F1A DYNC1H1 SON | 9.04e-08 | 331 | 108 | 10 | 29199018 | |
| Pubmed | MAP1B VPS4A TM9SF3 GEMIN5 TWF2 RFC1 NDUFS1 THADA COQ8A ASPH MRPS23 DDX23 ACAA2 HSD17B10 CDK1 TOP2A ATP5F1A DYNC1H1 KPNB1 | 9.30e-08 | 1440 | 108 | 19 | 30833792 | |
| Pubmed | SLC12A6 GLS2 MAP1B CENPF MYH7B TM9SF3 RBM42 CHD2 HMGCL TTC3 NDUFS1 PDIA4 RBM5 DDX23 DDX39A DDX39B TOP2A ATP5F1A KPNB1 | 9.50e-08 | 1442 | 108 | 19 | 35575683 | |
| Pubmed | TCAF1 MRPL12 ZC3H15 ACLY NOA1 GEMIN5 CHD2 USP9Y PDIA4 MRPS23 HSD17B10 CDK1 CDC73 HEATR5B ATP5F1A DYNC1H1 KPNB1 | 1.01e-07 | 1153 | 108 | 17 | 29845934 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ATP6V1C1 GNPDA1 ACLY GART GEMIN5 TWF2 PDIA4 NSFL1C GNPDA2 ACAA2 HSD17B10 CDK1 CDC73 KIF13A DDX39A DDX39B DYNC1H1 CAP1 KPNB1 | 1.09e-07 | 1455 | 108 | 19 | 22863883 |
| Pubmed | MAP1B ACLY TM9SF3 GART CKAP5 GEMIN5 NDUFS1 THADA RBM5 CDK1 PLK1 ATP5F1A KPNB1 | 1.38e-07 | 657 | 108 | 13 | 36180527 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | MYH7B ACLY TM9SF3 DDX23 HSD17B10 DDX39A DDX39B ATP5F1A DYNC1H1 | 1.68e-07 | 268 | 108 | 9 | 33024031 |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.87e-07 | 358 | 108 | 10 | 32460013 | |
| Pubmed | MAP1B ACLY NDUFS1 AK3 PDIA4 NSFL1C ABCD1 CDK1 DDX39A TOP2A ATP5F1A DYNC1H1 CAP1 KPNB1 | 2.06e-07 | 803 | 108 | 14 | 36517590 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | ATP6V1C1 TCAF1 MAP1B MRPL12 ZC3H15 GART CKAP5 GEMIN5 TWF2 RFC1 PDIA4 MRPS23 HSD17B10 DDX39A TOP2A ATP5F1A SON KPNB1 | 2.18e-07 | 1367 | 108 | 18 | 32687490 |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | ACLY GART PDIA4 EGFR MRPS23 ACAA2 HSD17B10 CDK1 TNS1 DDX39B ATP5F1A DYNC1H1 | 2.69e-07 | 580 | 108 | 12 | 35676659 |
| Pubmed | ACLY GART CKAP5 NDUFS1 MRPS23 HSD17B10 CDK1 DDX39B TOP2A ATP5F1A DYNC1H1 CAP1 KPNB1 | 3.18e-07 | 707 | 108 | 13 | 19738201 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | CENPF ZC3H15 ACLY TM9SF3 GART CKAP5 RFC1 EGFR ASPH MRPS23 CDK1 DDX39B TOP2A ATP5F1A DYNC1H1 KPNB1 CDK7 | 3.41e-07 | 1257 | 108 | 17 | 36526897 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MAP1B ZC3H15 ACLY CKAP5 GEMIN5 TTC3 PDIA4 NSFL1C DCLRE1A HSD17B10 R3HDM1 DDX39B SON | 4.16e-07 | 724 | 108 | 13 | 36232890 |
| Pubmed | SLC12A6 ATP6V1C1 NEDD4L MAP1B ACLY CKAP5 GEMIN5 TWF2 SHROOM2 NDUFS1 PACS1 CRYM TNS1 DDX39B ATP5F1A DYNC1H1 CAP1 KPNB1 | 4.25e-07 | 1431 | 108 | 18 | 37142655 | |
| Pubmed | SLC12A6 ZBTB38 WWP1 LAMA2 CHD2 TTC3 NDUFS1 RBM5 ACAA2 SON KPNB1 | 4.51e-07 | 497 | 108 | 11 | 23414517 | |
| Pubmed | ARRDC1 and ARRDC3 act as tumor suppressors in renal cell carcinoma by facilitating YAP1 degradation. | 5.05e-07 | 21 | 108 | 4 | 29416926 | |
| Pubmed | MRPL12 CENPF TWF2 DDX23 DDX39B ATP5F1A DYNC1H1 CAP1 SON KPNB1 CDK7 | 5.38e-07 | 506 | 108 | 11 | 30890647 | |
| Pubmed | 6.03e-07 | 312 | 108 | 9 | 37120454 | ||
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 6.70e-07 | 316 | 108 | 9 | 31665637 | |
| Pubmed | MRPL12 RFC1 DDX23 CDK1 CDC73 DDX39A DDX39B TOP2A DYNC1H1 CDK7 | 7.84e-07 | 419 | 108 | 10 | 15635413 | |
| Pubmed | A mitochondrial protein compendium elucidates complex I disease biology. | GLS2 MRPL12 ACLY NOA1 ACSS1 HMGCL NDUFS1 AK3 ACSM4 COQ8A MRPS23 ACAA2 HSD17B10 ABCD1 ATP5F1A | 8.80e-07 | 1047 | 108 | 15 | 18614015 |
| Pubmed | 1.01e-06 | 332 | 108 | 9 | 37433992 | ||
| Pubmed | Phosphorylation of Plk1 at Ser326 regulates its functions during mitotic progression. | 1.01e-06 | 7 | 108 | 3 | 18695677 | |
| Pubmed | 1.21e-06 | 250 | 108 | 8 | 33536335 | ||
| Pubmed | 1.24e-06 | 441 | 108 | 10 | 31239290 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | TCAF1 MAN1A1 KIF1A VPS4A ACLY TM9SF3 PDIA4 THADA ASPH ABCD1 HEATR5B QSOX2 DYNC1H1 KPNB1 | 1.37e-06 | 942 | 108 | 14 | 31073040 |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | MAP1B MRPL12 NOA1 RBM42 GEMIN5 RFC1 ASPH MRPS23 HSD17B10 CDC73 ATP5F1A SON | 1.39e-06 | 678 | 108 | 12 | 30209976 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | ZC3H15 CHD2 MRPS23 RBM5 DDX23 HSD17B10 R3HDM1 DDX39A DDX39B TOP2A DYNC1H1 SON KPNB1 | 1.39e-06 | 807 | 108 | 13 | 22681889 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.44e-06 | 256 | 108 | 8 | 33397691 | |
| Pubmed | 14-3-3 theta binding to cell cycle regulatory factors is enhanced by HIV-1 Vpr. | 1.61e-06 | 8 | 108 | 3 | 18445273 | |
| Pubmed | 1.96e-06 | 360 | 108 | 9 | 33111431 | ||
| Pubmed | ZC3H15 VPS4A NOA1 RBM42 GEMIN5 RFC1 ASPH MRPS23 DDX23 CDK1 TOP2A SON | 2.33e-06 | 713 | 108 | 12 | 29802200 | |
| Pubmed | 2.36e-06 | 191 | 108 | 7 | 33762435 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | MAP1B ACLY DDX23 MACROH2A2 HSD17B10 DDX39A DDX39B TOP2A ATP5F1A DYNC1H1 SON KPNB1 | 2.36e-06 | 714 | 108 | 12 | 28302793 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | CENPF ACLY RFC1 RBM5 DDX23 HSD17B10 CDC73 PLK1 RAB29 DDX39B TOP2A ATP5F1A SON KPNB1 | 2.42e-06 | 989 | 108 | 14 | 36424410 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | MRPL12 ACLY NOA1 TM9SF3 GART CHD2 HMGCL NDUFS1 AK3 PDIA4 EGFR ASPH MRPS23 ACAA2 QSOX2 ATP5F1A KPNB1 | 2.42e-06 | 1451 | 108 | 17 | 30550785 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CENPF CKAP5 RBM42 CHD2 RFC1 ZNF512B ASPH RBM5 DDX23 DCLRE1A CDC73 DDX39B TOP2A ATP5F1A SON KPNB1 | 2.50e-06 | 1294 | 108 | 16 | 30804502 |
| Pubmed | ACLY HMGCL NDUFS1 AK3 NSFL1C ASPH MRPS23 PGLS ACAA2 HSD17B10 ABCD1 ATP5F1A CAP1 | 2.76e-06 | 859 | 108 | 13 | 31536960 | |
| Pubmed | MRPL12 ZC3H15 TWF2 PDIA4 NSFL1C EGFR MAP4K5 ASPH CDK1 R3HDM1 PLK1 DDX39A QSOX2 CAP1 | 2.98e-06 | 1007 | 108 | 14 | 34597346 | |
| Pubmed | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. | 3.03e-06 | 283 | 108 | 8 | 18854154 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SLC12A6 NEDD4L KIF1A MAP1B WWP1 CHD2 TTC3 SHROOM2 ANO8 PACS1 THADA EGFR COQ8A ASPH ARHGEF9 RBM5 MACROH2A2 | 3.42e-06 | 1489 | 108 | 17 | 28611215 |
| Pubmed | VPS4A GART CKAP5 GEMIN5 NDUFS1 EGFR CDK1 PLK1 DDX39A ATP5F1A KPNB1 | 3.44e-06 | 613 | 108 | 11 | 22268729 | |
| Pubmed | 3.45e-06 | 288 | 108 | 8 | 38496616 | ||
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | MAP1B ACLY GART CKAP5 PDIA4 HSD17B10 DDX39B ATP5F1A CAP1 KPNB1 | 3.47e-06 | 495 | 108 | 10 | 28581483 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | TCAF1 GNPDA1 NEDD4L MAP1B CENPF ACLY MACROH2A2 CDC73 TOP2A CAP1 | 3.66e-06 | 498 | 108 | 10 | 36634849 |
| Pubmed | ADCY10 MAP1B ZC3H15 ACLY NOA1 GART RFC1 NDUFS1 AK3 MRPS23 HSD17B10 CDK1 PLK1 DDX39B ATP5F1A KPNB1 | 3.72e-06 | 1335 | 108 | 16 | 29229926 | |
| Pubmed | Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality. | 4.01e-06 | 207 | 108 | 7 | 31056398 | |
| Pubmed | 4.01e-06 | 207 | 108 | 7 | 20186120 | ||
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | ACLY TTC3 PDIA4 NSFL1C HSD17B10 CDK1 CDC73 PLK1 DDX39B ATP5F1A SON | 4.07e-06 | 624 | 108 | 11 | 33729478 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MAP1B CENPF CKAP5 RFC1 ASPH MACROH2A2 CDK1 CDC73 PLK1 DDX39A TOP2A SON | 4.41e-06 | 759 | 108 | 12 | 35915203 |
| Pubmed | 4.66e-06 | 300 | 108 | 8 | 28561026 | ||
| Pubmed | 4.91e-06 | 403 | 108 | 9 | 30562941 | ||
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | GLS2 MRPL12 ACLY NOA1 ACSS1 HMGCL NDUFS1 AK3 ACSM4 COQ8A MRPS23 ACAA2 ATP5F1A | 6.22e-06 | 926 | 108 | 13 | 20877624 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MAP1B MRPL12 ZC3H15 ACLY GART CKAP5 GEMIN5 RFC1 ZNF512B TOP2A ATP5F1A SON KPNB1 | 6.82e-06 | 934 | 108 | 13 | 33916271 |
| Pubmed | TCAF1 WWP1 GEMIN5 CHD2 TTC3 SHROOM2 PDIA4 PACS1 COQ8A KIF13A DDX39A TNS1 QSOX2 ATP5F1A | 6.90e-06 | 1084 | 108 | 14 | 11544199 | |
| Pubmed | ACLY GART TWF2 EGFR DDX23 MACROH2A2 CDK1 CDC73 DDX39A DDX39B TOP2A | 6.91e-06 | 660 | 108 | 11 | 32780723 | |
| Pubmed | ACLY WWP1 VPS4B GART RFC1 NDUFS1 NSFL1C HSD17B10 DDX39A DDX39B TOP2A ATP5F1A DYNC1H1 CAP1 KPNB1 | 7.39e-06 | 1247 | 108 | 15 | 27684187 | |
| Pubmed | MAP1B ACLY GART CKAP5 RBM5 DDX23 HSD17B10 CDC73 DDX39B ATP5F1A | 8.87e-06 | 551 | 108 | 10 | 34728620 | |
| Pubmed | ATP6V1C1 MAP1B ACLY NDUFS1 CRYM DDX39B ATP5F1A DYNC1H1 CAP1 KPNB1 | 9.01e-06 | 552 | 108 | 10 | 36293380 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 16949217 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 17428789 | ||
| Pubmed | Two mammalian glucosamine-6-phosphate deaminases: a structural and genetic study. | 9.55e-06 | 2 | 108 | 2 | 12965206 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 12616532 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 32961751 | ||
| Pubmed | Identification of pauses during formation of HIV-1 virus like particles. | 9.55e-06 | 2 | 108 | 2 | 24268138 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 20610707 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 10393249 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 31276916 | ||
| Pubmed | DNA Replication Determines Timing of Mitosis by Restricting CDK1 and PLK1 Activation. | 9.55e-06 | 2 | 108 | 2 | 30008317 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 38225262 | ||
| Interaction | KCNA3 interactions | ADCY10 NEDD4L MAP1B MYH7B ZC3H15 ACLY TM9SF3 GART CKAP5 CHD2 PDIA4 NSFL1C EGFR MAP4K5 HSD17B10 CDK1 DDX39A ATP5F1A DYNC1H1 CAP1 KPNB1 | 5.14e-09 | 871 | 107 | 21 | int:KCNA3 |
| Interaction | SIRT7 interactions | KIF1A MAP1B CENPF ACLY GART CKAP5 GEMIN5 CHD2 RFC1 NDUFS1 PDIA4 DDX23 CDK1 TOP2A DYNC1H1 CAP1 SON KPNB1 | 7.05e-08 | 744 | 107 | 18 | int:SIRT7 |
| Interaction | BIRC3 interactions | CENPF ZC3H15 VPS4A ACLY TM9SF3 GART CKAP5 GEMIN5 HMGCL RFC1 TTC3 NDUFS1 PDIA4 EGFR RBM5 HSD17B10 CDK1 CDC73 DDX39B TOP2A ATP5F1A DYNC1H1 CAP1 KPNB1 | 9.93e-08 | 1334 | 107 | 24 | int:BIRC3 |
| Interaction | SNRPA interactions | MAP1B RBM42 GEMIN5 EGFR MRPS23 DDX23 ACAA2 CDC73 DDX39A DDX39B TOP2A DYNC1H1 SON CDK7 | 2.65e-07 | 482 | 107 | 14 | int:SNRPA |
| Interaction | EFTUD2 interactions | TCAF1 NEDD4L MRPL12 ZC3H15 ACLY GART CKAP5 RBM42 GEMIN5 RFC1 EGFR ASPH MRPS23 PGLS DDX23 HSD17B10 CDK1 CDC73 DDX39B TOP2A ATP5F1A DYNC1H1 SON KPNB1 | 4.54e-07 | 1449 | 107 | 24 | int:EFTUD2 |
| Interaction | AHSA1 interactions | MAP1B ACLY CKAP5 EGFR COQ8A PLK1 DDX39A DDX39B TOP2A ATP5F1A KPNB1 | 4.73e-07 | 294 | 107 | 11 | int:AHSA1 |
| Interaction | C9orf78 interactions | ACLY CKAP5 RBM42 RFC1 NDUFS1 COQ8A ASPH DDX23 ACAA2 HSD17B10 PLK1 TOP2A ATP5F1A DYNC1H1 KPNB1 | 9.75e-07 | 620 | 107 | 15 | int:C9orf78 |
| Interaction | IFI16 interactions | MAP1B ZC3H15 ACLY GART CKAP5 RFC1 PDIA4 EGFR DDX23 MACROH2A2 CDK1 HEATR5B DDX39A TOP2A ATP5F1A SON | 1.12e-06 | 714 | 107 | 16 | int:IFI16 |
| Interaction | SERBP1 interactions | MAP1B MYH7B ACLY VPS4B TM9SF3 GART CKAP5 RBM42 NDUFS1 PDIA4 EGFR PGLS HSD17B10 CDK1 HEATR5B DDX39A QSOX2 TOP2A ATP5F1A DYNC1H1 TANGO6 KPNB1 CDK7 | 1.41e-06 | 1432 | 107 | 23 | int:SERBP1 |
| Interaction | EED interactions | ATP6V1C1 MAN1A1 MAP1B ACLY GART CKAP5 GEMIN5 TWF2 CHD2 NDUFS1 ZNF512B THADA RBM5 MACROH2A2 CDK1 PLK1 DDX39A DDX39B TOP2A ATP5F1A DYNC1H1 SON KPNB1 | 1.64e-06 | 1445 | 107 | 23 | int:EED |
| Interaction | CLPP interactions | MRPL12 NOA1 VPS4B ACSS1 TM9SF3 NDUFS1 AK3 EGFR COQ8A MRPS23 ACAA2 HSD17B10 QSOX2 ATP5F1A | 1.65e-06 | 562 | 107 | 14 | int:CLPP |
| Interaction | DLST interactions | MRPL12 GART CKAP5 NDUFS1 EGFR DDX23 MACROH2A2 HSD17B10 CDK1 TOP2A DYNC1H1 KPNB1 CDK7 | 2.00e-06 | 490 | 107 | 13 | int:DLST |
| Interaction | COX15 interactions | KIF1A MRPL12 GART NDUFS1 EGFR MRPS23 MACROH2A2 CDK1 TOP2A DYNC1H1 CDK7 | 2.74e-06 | 352 | 107 | 11 | int:COX15 |
| Interaction | OBSL1 interactions | CENPF ACLY GART RBM42 RFC1 PDIA4 ASPH DDX23 MACROH2A2 HSD17B10 CDK1 DDX39B TOP2A ATP5F1A DYNC1H1 SON KPNB1 | 5.23e-06 | 902 | 107 | 17 | int:OBSL1 |
| Interaction | HSPD1 interactions | MAP1B MRPL12 ACSS1 GART NDUFS1 AK3 CACNG6 EGFR MRPS23 RBM5 ACAA2 HSD17B10 CDC73 HEATR5B DDX39B ATP5F1A CAP1 CDK7 | 6.82e-06 | 1022 | 107 | 18 | int:HSPD1 |
| Interaction | KIF23 interactions | ACLY GART LAMA2 RFC1 USP9Y EGFR ASPH DDX23 MACROH2A2 HSD17B10 ABCD1 HEATR5B PLK1 TOP2A ATP5F1A DYNC1H1 SON KPNB1 | 7.69e-06 | 1031 | 107 | 18 | int:KIF23 |
| Interaction | BRCA1 interactions | CENPF ACLY GART CKAP5 GEMIN5 RFC1 PDIA4 EGFR DDX23 DCLRE1A CDK1 CDC73 PLK1 DDX39A DDX39B TOP2A DYNC1H1 CAP1 KPNB1 CDK7 | 8.12e-06 | 1249 | 107 | 20 | int:BRCA1 |
| Interaction | ETFDH interactions | 8.18e-06 | 52 | 107 | 5 | int:ETFDH | |
| Interaction | SHROOM2 interactions | 8.72e-06 | 25 | 107 | 4 | int:SHROOM2 | |
| Interaction | H1-0 interactions | 9.08e-06 | 256 | 107 | 9 | int:H1-0 | |
| Interaction | CUL7 interactions | MAP1B CENPF ACLY GART PDIA4 DDX23 MACROH2A2 HSD17B10 CDK1 PLK1 DDX39B TOP2A ATP5F1A DYNC1H1 SON KPNB1 | 9.64e-06 | 845 | 107 | 16 | int:CUL7 |
| Interaction | PAFAH1B1 interactions | 9.66e-06 | 258 | 107 | 9 | int:PAFAH1B1 | |
| Interaction | MSN interactions | MRPL12 GART CKAP5 SHROOM2 PDIA4 NSFL1C ACAA2 HSD17B10 CDC73 ATP5F1A | 1.04e-05 | 330 | 107 | 10 | int:MSN |
| Interaction | ARMC5 interactions | 1.19e-05 | 201 | 107 | 8 | int:ARMC5 | |
| Interaction | MECP2 interactions | ZBTB38 NEDD4L MAP1B ZC3H15 RBM42 CHD2 USP9Y NDUFS1 ZNF512B MRPS23 RBM5 DDX23 MACROH2A2 PLK1 DDX39A DDX39B DYNC1H1 SON KPNB1 CDK7 | 1.26e-05 | 1287 | 107 | 20 | int:MECP2 |
| Interaction | NR2C2 interactions | ATP6V1C1 ACLY ACSS1 TM9SF3 GART GEMIN5 CHD2 RFC1 NDUFS1 NSFL1C DDX23 HSD17B10 CDK1 PLK1 DDX39A DDX39B TOP2A ATP5F1A DYNC1H1 SON KPNB1 | 1.30e-05 | 1403 | 107 | 21 | int:NR2C2 |
| Interaction | NPM1 interactions | MAP1B MRPL12 CENPF ZC3H15 WWP1 RBM42 GEMIN5 RFC1 EGFR ARHGEF9 MRPS23 DDX23 MACROH2A2 CDK1 PLK1 TOP2A ATP5F1A SON CDK7 | 1.68e-05 | 1201 | 107 | 19 | int:NPM1 |
| Interaction | BAP1 interactions | MAP1B MRPL12 VPS4A ACLY WWP1 GART CKAP5 GEMIN5 RFC1 PDIA4 NSFL1C EGFR MRPS23 HSD17B10 CDK1 DDX39B ATP5F1A DYNC1H1 CAP1 KPNB1 | 1.71e-05 | 1314 | 107 | 20 | int:BAP1 |
| Interaction | COPS5 interactions | TCAF1 GNPDA1 RBM42 GEMIN5 PPP1R15A TTC3 ABCA10 EGFR MAP4K5 MRPS23 RBM5 KHK HSD17B10 PLK1 TOP2A ATP5F1A DYNC1H1 KPNB1 | 1.89e-05 | 1102 | 107 | 18 | int:COPS5 |
| Interaction | SNRPB interactions | ACLY RBM42 GEMIN5 PRR22 EGFR DDX23 KHK CDC73 DDX39A DDX39B DYNC1H1 SON | 1.94e-05 | 517 | 107 | 12 | int:SNRPB |
| Interaction | CEBPB interactions | MRPL12 ZC3H15 VPS4A ACLY GART RBM42 RFC1 PDIA4 EGFR MRPS23 DDX23 ACAA2 CDC73 DDX39A DDX39B TOP2A ATP5F1A DYNC1H1 CAP1 SON KPNB1 | 1.99e-05 | 1443 | 107 | 21 | int:CEBPB |
| Interaction | TOP2A interactions | ZBTB38 CKAP5 RFC1 EGFR DDX23 MACROH2A2 CDK1 CDC73 PLK1 TOP2A DYNC1H1 CDK7 | 2.06e-05 | 520 | 107 | 12 | int:TOP2A |
| Interaction | HSCB interactions | KIF1A MRPL12 NOA1 TM9SF3 HMGCL NDUFS1 EGFR ASPH MRPS23 ACAA2 HSD17B10 DDX39A DDX39B QSOX2 DYNC1H1 | 2.69e-05 | 817 | 107 | 15 | int:HSCB |
| Interaction | CEBPA interactions | ZC3H15 ACLY TM9SF3 CKAP5 TWF2 RFC1 PDIA4 NSFL1C RBM5 DDX23 CDK1 CDC73 PLK1 DDX39A TOP2A DYNC1H1 CAP1 KPNB1 CDK7 | 2.76e-05 | 1245 | 107 | 19 | int:CEBPA |
| Interaction | ATP1B1 interactions | 3.08e-05 | 167 | 107 | 7 | int:ATP1B1 | |
| Interaction | HDAC6 interactions | ACLY GART GEMIN5 PDIA4 BCL11B EGFR OR10H1 MRPS23 ACAA2 HSD17B10 CDK1 PLK1 TNS1 DDX39B ATP5F1A DYNC1H1 | 3.08e-05 | 929 | 107 | 16 | int:HDAC6 |
| Interaction | RBM39 interactions | ZBTB38 MAP1B ACLY RBM42 GEMIN5 EGFR MRPS23 DDX23 MACROH2A2 HSD17B10 DDX39A DDX39B TOP2A ATP5F1A DYNC1H1 SON KPNB1 | 3.37e-05 | 1042 | 107 | 17 | int:RBM39 |
| Interaction | ACO2 interactions | 3.53e-05 | 304 | 107 | 9 | int:ACO2 | |
| Interaction | MCM4 interactions | 3.72e-05 | 306 | 107 | 9 | int:MCM4 | |
| Interaction | MEX3A interactions | 3.82e-05 | 384 | 107 | 10 | int:MEX3A | |
| Interaction | PDHA1 interactions | MAP1B MRPL12 NOA1 ACSS1 NDUFS1 PREX2 AK3 COQ8A ASPH MRPS23 HSD17B10 ATP5F1A DYNC1H1 KPNB1 | 4.28e-05 | 750 | 107 | 14 | int:PDHA1 |
| Interaction | CCDC8 interactions | NEDD4L MAP1B ACLY GART CKAP5 ZNF512B PDIA4 CDK1 HEATR5B TOP2A ATP5F1A DYNC1H1 KPNB1 | 4.47e-05 | 656 | 107 | 13 | int:CCDC8 |
| Interaction | RICTOR interactions | MAN1A1 MAP1B ACLY GART CKAP5 NDUFS1 PDIA4 EGFR ASPH HSD17B10 PLK1 DDX39A ATP5F1A DYNC1H1 | 4.87e-05 | 759 | 107 | 14 | int:RICTOR |
| Interaction | PLOD2 interactions | 4.96e-05 | 180 | 107 | 7 | int:PLOD2 | |
| Interaction | PINK1 interactions | NEDD4L MAP1B ACLY GART NDUFS1 PDIA4 NSFL1C ACAA2 HSD17B10 DDX39B ATP5F1A DYNC1H1 SON | 6.35e-05 | 679 | 107 | 13 | int:PINK1 |
| Interaction | ISG15 interactions | MYH7B ZC3H15 ACLY TM9SF3 NSFL1C DDX23 DDX39A DDX39B TOP2A ATP5F1A DYNC1H1 | 6.40e-05 | 494 | 107 | 11 | int:ISG15 |
| Interaction | CIT interactions | CENPF VPS4A GART CKAP5 RBM42 CHD2 TTC3 ASPH RBM5 DDX23 ACAA2 MACROH2A2 CDK1 CDC73 DDX39B TOP2A ATP5F1A DYNC1H1 SON KPNB1 | 6.88e-05 | 1450 | 107 | 20 | int:CIT |
| Interaction | SSRP1 interactions | TECTB GEMIN5 CHD2 RFC1 EGFR DDX23 MACROH2A2 CDC73 DDX39A DDX39B TOP2A SON CDK7 | 6.94e-05 | 685 | 107 | 13 | int:SSRP1 |
| Interaction | TUFM interactions | MAP1B MRPL12 NDUFS1 PDIA4 NSFL1C EGFR ASPH MRPS23 HSD17B10 PLK1 DDX39B ATP5F1A CAP1 | 7.04e-05 | 686 | 107 | 13 | int:TUFM |
| Interaction | ACE2 interactions | ZC3H15 ACLY TM9SF3 CKAP5 RBM42 GEMIN5 SHROOM2 PDIA4 EGFR MRPS23 HSD17B10 CDK1 DDX39B TOP2A ATP5F1A DYNC1H1 KPNB1 | 7.08e-05 | 1106 | 107 | 17 | int:ACE2 |
| Interaction | THOC5 interactions | 7.10e-05 | 131 | 107 | 6 | int:THOC5 | |
| Interaction | TMEM267 interactions | 7.75e-05 | 16 | 107 | 3 | int:TMEM267 | |
| Interaction | DYRK3 interactions | 7.90e-05 | 43 | 107 | 4 | int:DYRK3 | |
| Interaction | STIP1 interactions | SLC12A6 ACLY GART CKAP5 GEMIN5 NDUFS1 EGFR COQ8A HSD17B10 CDK1 CDC73 DDX39B DYNC1H1 CAP1 SON KPNB1 | 7.95e-05 | 1006 | 107 | 16 | int:STIP1 |
| Interaction | PHB1 interactions | MAP1B MRPL12 VPS4B GART USP9Y NDUFS1 PDIA4 EGFR HSD17B10 CDK1 DDX39A DDX39B ATP5F1A DYNC1H1 SON KPNB1 CDK7 | 8.53e-05 | 1123 | 107 | 17 | int:PHB1 |
| Interaction | DNM1L interactions | 9.35e-05 | 345 | 107 | 9 | int:DNM1L | |
| Interaction | TMEM255A interactions | 9.37e-05 | 17 | 107 | 3 | int:TMEM255A | |
| Interaction | DDRGK1 interactions | MRPL12 ZC3H15 CKAP5 RBM42 GEMIN5 RFC1 COQ8A ASPH MRPS23 RBM5 DDX23 HSD17B10 CDK1 CDC73 DDX39A TOP2A ATP5F1A KPNB1 | 9.66e-05 | 1249 | 107 | 18 | int:DDRGK1 |
| Interaction | TERF1 interactions | 9.77e-05 | 347 | 107 | 9 | int:TERF1 | |
| Interaction | YWHAE interactions | NEDD4L PLAAT4 MAP1B ACLY CKAP5 TWF2 TTC3 SHROOM2 PDIA4 PACS1 CDC73 R3HDM1 DDX39A TOP2A ATP5F1A DYNC1H1 KPNB1 CDK7 | 1.04e-04 | 1256 | 107 | 18 | int:YWHAE |
| Interaction | RUVBL2 interactions | ZBTB38 MAP1B GEMIN5 EGFR MACROH2A2 HSD17B10 CDC73 TOP2A DYNC1H1 TANGO6 KPNB1 CDK7 | 1.05e-04 | 616 | 107 | 12 | int:RUVBL2 |
| Interaction | UFL1 interactions | MAP1B MRPL12 ZC3H15 ACLY GART RBM42 EGFR ASPH MRPS23 DDX23 HSD17B10 CDK1 CDC73 DDX39A ATP5F1A KPNB1 | 1.06e-04 | 1031 | 107 | 16 | int:UFL1 |
| Interaction | SNCA interactions | TCAF1 GNPDA1 NEDD4L MAP1B CENPF ACLY EGFR MACROH2A2 CDC73 PLK1 TOP2A DYNC1H1 CAP1 | 1.08e-04 | 716 | 107 | 13 | int:SNCA |
| Interaction | HNRNPU interactions | NOA1 GART CKAP5 RBM42 RFC1 EGFR MAP4K5 DDX23 PLK1 DDX39A DDX39B TOP2A ATP5F1A DYNC1H1 KPNB1 CDK7 | 1.11e-04 | 1035 | 107 | 16 | int:HNRNPU |
| Interaction | SEC61G interactions | 1.12e-04 | 47 | 107 | 4 | int:SEC61G | |
| Interaction | FGD5 interactions | 1.19e-04 | 207 | 107 | 7 | int:FGD5 | |
| Interaction | KCTD13 interactions | SLC12A6 ATP6V1C1 NEDD4L MAP1B ACLY CKAP5 GEMIN5 TWF2 SHROOM2 NDUFS1 PACS1 CRYM NSFL1C TNS1 DDX39B ATP5F1A DYNC1H1 CAP1 KPNB1 | 1.26e-04 | 1394 | 107 | 19 | int:KCTD13 |
| Interaction | CAPZB interactions | ZC3H15 GEMIN5 TWF2 PTN EGFR MRPS23 RBM5 HSD17B10 CDK1 CDC73 DDX39B TOP2A ATP5F1A DYNC1H1 CAP1 KPNB1 | 1.29e-04 | 1049 | 107 | 16 | int:CAPZB |
| Interaction | SLC9A3 interactions | 1.33e-04 | 19 | 107 | 3 | int:SLC9A3 | |
| Interaction | TXNIP interactions | 1.38e-04 | 212 | 107 | 7 | int:TXNIP | |
| Interaction | BCL2L1 interactions | 1.42e-04 | 213 | 107 | 7 | int:BCL2L1 | |
| Interaction | VDAC1 interactions | MAP1B MRPL12 NDUFS1 EGFR COQ8A ACAA2 CDK1 TOP2A ATP5F1A KPNB1 CDK7 | 1.45e-04 | 542 | 107 | 11 | int:VDAC1 |
| Interaction | RTF1 interactions | 1.50e-04 | 150 | 107 | 6 | int:RTF1 | |
| Interaction | FH interactions | 1.51e-04 | 215 | 107 | 7 | int:FH | |
| Interaction | ZC3H7A interactions | 1.51e-04 | 215 | 107 | 7 | int:ZC3H7A | |
| Interaction | H2AZ1 interactions | 1.62e-04 | 371 | 107 | 9 | int:H2AZ1 | |
| Interaction | PLOD1 interactions | 1.66e-04 | 292 | 107 | 8 | int:PLOD1 | |
| Interaction | THOC2 interactions | 1.69e-04 | 219 | 107 | 7 | int:THOC2 | |
| Interaction | CUL4A interactions | GLS2 MAP1B CENPF CKAP5 HMGCL ABCA10 ACSM4 EGFR COQ8A HSD17B10 PLK1 DDX39A DDX39B KPNB1 | 1.69e-04 | 854 | 107 | 14 | int:CUL4A |
| Interaction | NUCKS1 interactions | 1.74e-04 | 220 | 107 | 7 | int:NUCKS1 | |
| Interaction | SLFN11 interactions | 1.79e-04 | 376 | 107 | 9 | int:SLFN11 | |
| Interaction | RAB1A interactions | 1.82e-04 | 464 | 107 | 10 | int:RAB1A | |
| Interaction | MDH2 interactions | MAP1B MRPL12 NOA1 NDUFS1 AK3 MRPS23 DDX23 ACAA2 HSD17B10 QSOX2 ATP5F1A | 1.90e-04 | 559 | 107 | 11 | int:MDH2 |
| Interaction | C9orf72 interactions | TCAF1 VPS4A ACLY VPS4B TM9SF3 GART RFC1 NDUFS1 COQ8A DDX23 HSD17B10 CDK1 PLK1 DDX39A DDX39B ATP5F1A DYNC1H1 KPNB1 | 1.91e-04 | 1319 | 107 | 18 | int:C9orf72 |
| Interaction | AAR2 interactions | TCAF1 ACLY GART GEMIN5 EGFR PGLS DDX23 HSD17B10 CDK1 ATP5F1A DYNC1H1 KPNB1 | 1.91e-04 | 657 | 107 | 12 | int:AAR2 |
| Interaction | SNRPD3 interactions | 1.93e-04 | 380 | 107 | 9 | int:SNRPD3 | |
| Interaction | ARRDC2 interactions | 1.94e-04 | 54 | 107 | 4 | int:ARRDC2 | |
| Interaction | SNRNP70 interactions | MAP1B ZC3H15 VPS4A NOA1 RBM42 GEMIN5 RFC1 MAP4K5 ASPH MRPS23 DDX23 CDK1 DDX39B TOP2A SON | 2.15e-04 | 984 | 107 | 15 | int:SNRNP70 |
| Interaction | ATP1B3 interactions | 2.34e-04 | 231 | 107 | 7 | int:ATP1B3 | |
| Interaction | LONP1 interactions | MRPL12 TM9SF3 NDUFS1 NSFL1C EGFR COQ8A ASPH MRPS23 HSD17B10 DYNC1H1 | 2.35e-04 | 479 | 107 | 10 | int:LONP1 |
| Interaction | AFAP1L2 interactions | 2.39e-04 | 23 | 107 | 3 | int:AFAP1L2 | |
| Interaction | ERCC1 interactions | 2.39e-04 | 57 | 107 | 4 | int:ERCC1 | |
| Interaction | DDX23 interactions | 2.39e-04 | 480 | 107 | 10 | int:DDX23 | |
| Interaction | BABAM1 interactions | 2.43e-04 | 105 | 107 | 5 | int:BABAM1 | |
| Interaction | HUWE1 interactions | TCAF1 MAP1B ACLY TTC3 NDUFS1 PREX2 NSFL1C EGFR COQ8A HSD17B10 CDK1 KIF13A DDX39B ATP5F1A DYNC1H1 KPNB1 | 2.46e-04 | 1110 | 107 | 16 | int:HUWE1 |
| Interaction | ECT2 interactions | ACLY USP9Y EGFR DDX23 MACROH2A2 HSD17B10 ABCD1 CDK1 PLK1 TOP2A ATP5F1A DYNC1H1 SON KPNB1 | 2.50e-04 | 887 | 107 | 14 | int:ECT2 |
| Interaction | HK1 interactions | 2.53e-04 | 234 | 107 | 7 | int:HK1 | |
| Interaction | LARP7 interactions | MRPL12 ACLY GART RBM42 GEMIN5 CHD2 MRPS23 DDX23 MACROH2A2 HSD17B10 CDK1 CDC73 HEATR5B ATP5F1A DYNC1H1 KPNB1 | 2.54e-04 | 1113 | 107 | 16 | int:LARP7 |
| Interaction | TRIM28 interactions | MAP1B CENPF ACLY GEMIN5 BCL11B EGFR MRPS23 PGLS ACAA2 HSD17B10 CDK1 CDC73 PLK1 DDX39A DDX39B TOP2A ATP5F1A DYNC1H1 SON | 2.58e-04 | 1474 | 107 | 19 | int:TRIM28 |
| Interaction | MAPT interactions | MAP1B MYH7B ACLY GART CKAP5 USP9Y PTN NSFL1C EGFR ACAA2 MACROH2A2 HSD17B10 CDK1 DYNC1H1 CAP1 KPNB1 | 2.69e-04 | 1119 | 107 | 16 | int:MAPT |
| GeneFamily | AAA ATPases|ESCRT-IV | 4.94e-05 | 3 | 74 | 2 | 1120 | |
| GeneFamily | DEAD-box helicases | 6.74e-04 | 42 | 74 | 3 | 499 | |
| GeneFamily | AAA ATPases | 1.33e-03 | 53 | 74 | 3 | 413 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | TCAF1 MRPL12 CENPF ZC3H15 ACLY GART CKAP5 RFC1 PDIA4 CDK1 R3HDM1 PLK1 DDX39A TOP2A KPNB1 | 3.33e-08 | 612 | 108 | 15 | M4772 |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | ATP6V1C1 MAN1A1 ZC3H15 DDN USP9Y TTC3 PTN CRYM BCL11B NSFL1C ASPH ARHGEF9 R3HDM1 ATP5F1A DYNC1H1 CAP1 SON KPNB1 CDK7 | 7.66e-07 | 1248 | 108 | 19 | M17728 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.76e-06 | 199 | 108 | 8 | M5893 | |
| Coexpression | LY_AGING_OLD_DN | 3.50e-06 | 56 | 108 | 5 | M18789 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | KIF1A CENPF CKAP5 RFC1 TTC3 ANO8 ZNF512B PTN SLC9A5 CDK1 PLK1 TOP2A PMM1 | 4.62e-06 | 680 | 108 | 13 | MM456 |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | CENPF ACLY WWP1 TM9SF3 GART CKAP5 GEMIN5 RFC1 NTN4 SLC9A3 NSFL1C MACROH2A2 CDK1 PLK1 DDX39A TNS1 TOP2A KPNB1 | 5.27e-06 | 1290 | 108 | 18 | M80 |
| Coexpression | KAAB_HEART_ATRIUM_VS_VENTRICLE_DN | 1.33e-05 | 262 | 108 | 8 | M2584 | |
| Coexpression | TSANG_PBMC_FLUVIRIN_PANDEMRIX_ADULT_CORR_WITH_CELL_FREQ_CD27HI_CD38HI_CD20_NEG_PLASMABLASTS_AND_CD38PLUS_OF_IGD_CD27PLUS_MEM_B_CELLS_7DY_POSITIVE | 1.80e-05 | 78 | 108 | 5 | M41196 | |
| Coexpression | GSE17721_CTRL_VS_LPS_12H_BMDC_UP | 1.91e-05 | 199 | 108 | 7 | M3701 | |
| Coexpression | WHITFIELD_CELL_CYCLE_LITERATURE | 3.26e-05 | 44 | 108 | 4 | M2066 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | ZBTB38 CENPF GART CKAP5 RFC1 TTC3 EGFR MAP4K5 CDK1 DDX39A TOP2A CDK7 | 4.29e-05 | 721 | 108 | 12 | M10237 |
| Coexpression | SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP | 4.36e-05 | 154 | 108 | 6 | M3766 | |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 4.52e-05 | 155 | 108 | 6 | M39041 | |
| Coexpression | JEON_SMAD6_TARGETS_DN | 6.28e-05 | 19 | 108 | 3 | M13678 | |
| Coexpression | HALLMARK_PEROXISOME | 7.20e-05 | 104 | 108 | 5 | M5949 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_2H_DN | 7.80e-05 | 171 | 108 | 6 | M2990 | |
| Coexpression | BLUM_RESPONSE_TO_SALIRASIB_DN | 8.61e-05 | 341 | 108 | 8 | M2879 | |
| Coexpression | ZHONG_PFC_C1_MICROGLIA | 9.65e-05 | 257 | 108 | 7 | M39103 | |
| Coexpression | GSE14415_INDUCED_VS_NATURAL_TREG_DN | 1.07e-04 | 181 | 108 | 6 | M2969 | |
| Coexpression | MYC_UP.V1_UP | 1.07e-04 | 181 | 108 | 6 | M2711 | |
| Coexpression | GCNP_SHH_UP_LATE.V1_UP | 1.07e-04 | 181 | 108 | 6 | M2641 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | ATP6V1C1 TCAF1 ZBTB38 GNPDA1 KIF1A MAP1B ACLY TTC3 ARHGEF9 KIF13A RAB29 TNS1 DYNC1H1 | 1.41e-04 | 946 | 108 | 13 | M39169 |
| Coexpression | RHODES_CANCER_META_SIGNATURE | 1.52e-04 | 65 | 108 | 4 | M1345 | |
| Coexpression | GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN | 1.79e-04 | 199 | 108 | 6 | M8979 | |
| Coexpression | GSE22886_TCELL_VS_BCELL_NAIVE_UP | 1.79e-04 | 199 | 108 | 6 | M4425 | |
| Coexpression | GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_DN | 1.84e-04 | 200 | 108 | 6 | M7741 | |
| Coexpression | GSE14308_INDUCED_VS_NATURAL_TREG_UP | 1.84e-04 | 200 | 108 | 6 | M3396 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP | 1.84e-04 | 200 | 108 | 6 | M4622 | |
| Coexpression | GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_DN | 1.84e-04 | 200 | 108 | 6 | M5986 | |
| Coexpression | GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_UP | 1.84e-04 | 200 | 108 | 6 | M8308 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_DN | 1.84e-04 | 200 | 108 | 6 | M5300 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 1.84e-04 | 200 | 108 | 6 | M5901 | |
| Coexpression | GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_DN | 1.84e-04 | 200 | 108 | 6 | M5592 | |
| Coexpression | GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_DN | 1.84e-04 | 200 | 108 | 6 | M3607 | |
| Coexpression | GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_DN | 1.84e-04 | 200 | 108 | 6 | M9277 | |
| Coexpression | GSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP | 1.84e-04 | 200 | 108 | 6 | M9216 | |
| Coexpression | GSE7852_LN_VS_THYMUS_TCONV_DN | 1.84e-04 | 200 | 108 | 6 | M5746 | |
| Coexpression | KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_UP | 1.84e-04 | 200 | 108 | 6 | M3023 | |
| Coexpression | REICHERT_MITOSIS_LIN9_TARGETS | 1.85e-04 | 27 | 108 | 3 | M2483 | |
| Coexpression | WELCSH_BRCA1_TARGETS_UP | 1.89e-04 | 201 | 108 | 6 | M5490 | |
| Coexpression | REICHERT_MITOSIS_LIN9_TARGETS | 2.07e-04 | 28 | 108 | 3 | MM1323 | |
| Coexpression | BENPORATH_NANOG_TARGETS | TCAF1 NEDD4L GART CHD2 ANO8 AK3 PTN DDX23 CDK1 R3HDM1 DDX39A TOP2A SON | 2.15e-04 | 988 | 108 | 13 | M6616 |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING | 2.51e-04 | 212 | 108 | 6 | MM3816 | |
| Coexpression | TARTE_PLASMA_CELL_VS_PLASMABLAST_DN | 2.87e-04 | 307 | 108 | 7 | M19745 | |
| Coexpression | SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_DN | 3.20e-04 | 143 | 108 | 5 | M40889 | |
| Coexpression | HORIUCHI_WTAP_TARGETS_DN | 3.68e-04 | 320 | 108 | 7 | M10279 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.33e-09 | 197 | 108 | 9 | 41bdea47b9b1f6415a866a515d1535ea942fdede | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-07 | 192 | 108 | 7 | a42aed9e563f5f4af029b8804c104f11ad227a8f | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 5.32e-07 | 197 | 108 | 7 | 1bb8f9535a9ab6c7a444bcbe346fcc0a13b09bdf | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.51e-07 | 198 | 108 | 7 | 2445c9ff8e3f69314bdcb04faf7735272b916242 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.51e-07 | 198 | 108 | 7 | 2d8d4eb21b4fe3cc178b3518b3ea39c2d9650f24 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.51e-07 | 198 | 108 | 7 | 36897e17de2e22ee6b23920ee6e60931903f3e5c | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 5.70e-07 | 199 | 108 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.70e-07 | 199 | 108 | 7 | 89d7622c4ae146900d963ac68c6bf011e8674665 | |
| ToppCell | Transverse-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass | 5.89e-07 | 200 | 108 | 7 | 617a6a42f7b31eb3c45bdceaf55a591b6de7f154 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B_plasma-Plasmablasts|lymph-node_spleen / Manually curated celltypes from each tissue | 5.89e-07 | 200 | 108 | 7 | b0d708715f09ec1f67fdef3b100a91c8ff2747a7 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Cdh13|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.01e-06 | 136 | 108 | 6 | 1f3000d5f105c87c80f8ae1dd2264bcd7f757a9c | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.94e-06 | 152 | 108 | 6 | f748ee34167f79ecda116aa1914afab47403385a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.38e-06 | 175 | 108 | 6 | 9142ed8ca2f1c0c518deb21988221406f62fe38c | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.38e-06 | 175 | 108 | 6 | 8958c5c30437d20a4abd70d7527990f7e2a68b93 | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)|World / shred by cell type and Timepoint | 4.67e-06 | 177 | 108 | 6 | 05c57578142a6662f18b294d5cc11e6efd6b0f8e | |
| ToppCell | Control-Developping_Plasmablast|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.99e-06 | 179 | 108 | 6 | 9383568f78b07b8cca72ece5d15fea209aa54ea9 | |
| ToppCell | control-Lymphoid-NKT-proliferating|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.15e-06 | 180 | 108 | 6 | 535535a67b3f3320bad2f98b1bc98a7b0ee77840 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.31e-06 | 181 | 108 | 6 | d74ee84146a72fd7cddf287f2e66d47d2c683bc4 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.48e-06 | 182 | 108 | 6 | 942c18a27b22fb33a5200d5717cad972f3ef0576 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.66e-06 | 183 | 108 | 6 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.02e-06 | 185 | 108 | 6 | 6aeae77a087d695b1e58c5f63265e7113aa2e343 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.40e-06 | 187 | 108 | 6 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.60e-06 | 188 | 108 | 6 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.60e-06 | 188 | 108 | 6 | ecba5d06cbf3254448255a2aeefffe711f43310e | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.60e-06 | 188 | 108 | 6 | 95d0a796d62ce6d121e2028c378faffc14b35275 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.60e-06 | 188 | 108 | 6 | 8cf135da4d1d2500755d2809d60b41509af9fa8b | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_plasma-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.81e-06 | 189 | 108 | 6 | 59e6fec454de621119571d4a8ec48be3bf02a32e | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_plasma|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.81e-06 | 189 | 108 | 6 | 43f25fb7257eab05df921ffcd5a6e49c78a03e3a | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 7.23e-06 | 191 | 108 | 6 | 210a0f1a71df2508cbfc73d6868a2122338b9a1c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.23e-06 | 191 | 108 | 6 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.23e-06 | 191 | 108 | 6 | 0ba5b112a82e489f5a21966f78a403a7436ce73b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.23e-06 | 191 | 108 | 6 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 7.45e-06 | 192 | 108 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.67e-06 | 193 | 108 | 6 | a332dfdcc48c405020014e644aa4d14fda98cc86 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-Cycling_T|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.67e-06 | 193 | 108 | 6 | bec113472c40c0106a9427248cbcf54548797596 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.90e-06 | 194 | 108 | 6 | 7a66bd7d4fc9c6db861cedd2487f241e406869d1 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B_plasma|lymph-node_spleen / Manually curated celltypes from each tissue | 7.90e-06 | 194 | 108 | 6 | 42f43cac0dec704afd18143192e3ab68360ea076 | |
| ToppCell | (3)_Chondrocytes-(33)_Chondro-prol/rest|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | 7.90e-06 | 194 | 108 | 6 | 4a207630d72059345b10010f5cfd3b1462458324 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-06 | 194 | 108 | 6 | 5d60262a512590d60bc795d9a0e03c0219e3e15e | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.90e-06 | 194 | 108 | 6 | 5a519538327029ad2b880ef9647e2ac6ab3961a4 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 8.14e-06 | 195 | 108 | 6 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 195 | 108 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 195 | 108 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 8.38e-06 | 196 | 108 | 6 | 36ed1918f70b6f5760bb088b15ce422998055cc7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.62e-06 | 197 | 108 | 6 | 4ea3f57cd88b8a6bb7cb4b9e3545c0fa8f331886 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.62e-06 | 197 | 108 | 6 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_dorsal_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 8.87e-06 | 198 | 108 | 6 | 5f0964c3aa7e1dc52cbb46e754078920b65bcb88 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.87e-06 | 198 | 108 | 6 | 06888fe2d42ac66ac12157608becd42764e0d034 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 8.87e-06 | 198 | 108 | 6 | 629d674a9c9108c1acb3f7af57bbdbf34bb0528e | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.87e-06 | 198 | 108 | 6 | c3dd887c95587f930b7afd32385627a9fa029ca4 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.87e-06 | 198 | 108 | 6 | 7225a6194c52b01c581e58d3cda107c4af96dc4f | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.87e-06 | 198 | 108 | 6 | 2ee8ac82ef1b8ebabc8dd824211bbb471f2af8ac | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1-28|World / Primary Cells by Cluster | 9.13e-06 | 199 | 108 | 6 | 787688b68ae5d8768c0a24673ae07ab07616764a | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_Plasmablasts|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.13e-06 | 199 | 108 | 6 | 624a807fae0a080a4e6755dcb374c25b6f2d2cfe | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-B_cells-Cycling_plasma_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.13e-06 | 199 | 108 | 6 | c9d15c84b9f8c87b4ea0008be7d5efc5f45efd1a | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1|World / Primary Cells by Cluster | 9.13e-06 | 199 | 108 | 6 | 72823f26ecabcae1b514b7629cfce010c97b929a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_dorsal_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 9.13e-06 | 199 | 108 | 6 | ca17e8c0f5bc2c41ce28351a7418d934404e563b | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.13e-06 | 199 | 108 | 6 | 0da69ca107e826740f0ba3159012aa25e1b9da6a | |
| ToppCell | Mild/Remission-Developping_Plasmablast|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.13e-06 | 199 | 108 | 6 | 58c772ec763109a4009f52424fbb214fc23d0c09 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 9.13e-06 | 199 | 108 | 6 | d8f904f531bfe091b7d8caaa147ea4a03d627995 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_Highly_activated_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.13e-06 | 199 | 108 | 6 | f9bf94ab6b5b134f5b98a65340843b147941ab58 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.13e-06 | 199 | 108 | 6 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma|TCGA-Bladder / Sample_Type by Project: Shred V9 | 9.13e-06 | 199 | 108 | 6 | 8ee3dbc0a92de5f3865e5484970ae2aab7d1a956 | |
| ToppCell | TCGA-Bladder-Primary_Tumor|TCGA-Bladder / Sample_Type by Project: Shred V9 | 9.13e-06 | 199 | 108 | 6 | c403e28def2e14f5931cd73b4fb9a4078c0439f8 | |
| ToppCell | Mild/Remission-Developping_Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.13e-06 | 199 | 108 | 6 | 1dda6116de639140c2d6f5012b7ab9ad0f737ae1 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 9.40e-06 | 200 | 108 | 6 | 5f2fbd789cc16af411a01c3199583888b260ae91 | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 9.40e-06 | 200 | 108 | 6 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 9.40e-06 | 200 | 108 | 6 | 548a0f486ab8745da107f2815914dbf873a6e3c8 | |
| ToppCell | Severe-Developping_Plasmablast|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.40e-06 | 200 | 108 | 6 | 6d0cd00e52568d23597cc2a4059bd967d7d2dab5 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.40e-06 | 200 | 108 | 6 | 38e681997913fcbc93f4e1715820e53844376eab | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.40e-06 | 200 | 108 | 6 | 0de9e7412a1725a8acd51820aa3135a112ced36c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 9.40e-06 | 200 | 108 | 6 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD8_T_cells|Lymphoid / Condition, Lineage and Cell class | 9.40e-06 | 200 | 108 | 6 | 4556bb626ca1a00a6db13d2adb35acb8ba848f9c | |
| ToppCell | Severe-Developping_Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.40e-06 | 200 | 108 | 6 | 80639e0d2ddaae36ac7634a4f03e8809af7316e3 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital|World / Primary Cells by Cluster | 9.40e-06 | 200 | 108 | 6 | 6bbe8e1f3e91678f1bfb14945365c1578a59a604 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19|World / Primary Cells by Cluster | 9.40e-06 | 200 | 108 | 6 | c831d9e0a7178e3634da45548f91fa9e8dc6557c | |
| ToppCell | Endothelial-H_(cycle)|World / shred on cell class and cell subclass (v4) | 1.83e-05 | 133 | 108 | 5 | 8e3005114761feee028c496cc739e607b35d7831 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Prlr_(Entorhinal_cortex?)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.90e-05 | 65 | 108 | 4 | 57d0d892dab8bc8465067feeff279c967a43b781 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Prlr_(Entorhinal_cortex?)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.90e-05 | 65 | 108 | 4 | aba26f607f35c2920cdf956309285ad9e7b758a7 | |
| ToppCell | Endothelial-Endothelial-H_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 2.18e-05 | 138 | 108 | 5 | a1f41a5a9da40adcc343722baef78c603599c3f0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.57e-05 | 161 | 108 | 5 | 2165897924c790fec43502283f1df221c56c1e9f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.84e-05 | 163 | 108 | 5 | 2d6fd2562d78be9f83fa35d811eb7e27eb8cc5d1 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.84e-05 | 163 | 108 | 5 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.98e-05 | 164 | 108 | 5 | ad508f53009efdd1dae7abcdb5431387f3f7e7b2 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.98e-05 | 164 | 108 | 5 | 0662cd9d21608efacc336e0a582859f3b9a4951d | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.13e-05 | 165 | 108 | 5 | 26c750f10f6401752e2e63d91dc844c81b29d735 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.43e-05 | 167 | 108 | 5 | d21635df8b74189e3309eaf435af381fbe412574 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.59e-05 | 168 | 108 | 5 | 2082b15fc7935a211f1c61506b305af5501a21ad | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.59e-05 | 168 | 108 | 5 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.75e-05 | 169 | 108 | 5 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.75e-05 | 169 | 108 | 5 | a1efc20e34a81ae32f8d278a5486811ade03ef24 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.91e-05 | 170 | 108 | 5 | a7184dc41f90caa753860ed0f65a18133f84bc5f | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.91e-05 | 170 | 108 | 5 | a0d6466e00bd3dc07f644ba3f87d5b421fd479d5 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.91e-05 | 170 | 108 | 5 | 6b91d4cbe0697b65bfb2e099e7a9b39ea2fba3a9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.08e-05 | 171 | 108 | 5 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 6.08e-05 | 171 | 108 | 5 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.08e-05 | 171 | 108 | 5 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.08e-05 | 171 | 108 | 5 | 0eea035fde32cc2a75a0d4227911edb5d54ed47e | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.25e-05 | 172 | 108 | 5 | 7f3d0ef18f5df1ed80498d435b0378ca398c0b88 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.25e-05 | 172 | 108 | 5 | dd9ba79e1542fe9fa2c319077d83dd3fc0158f46 | |
| Computational | Neighborhood of RRM2 | 1.33e-04 | 40 | 71 | 4 | GNF2_RRM2 | |
| Computational | Neighborhood of HMMR | 2.52e-04 | 47 | 71 | 4 | GNF2_HMMR | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.96e-04 | 49 | 71 | 4 | GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_CELL_CYCLE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.96e-04 | 49 | 71 | 4 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CELL_CYCLE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.96e-04 | 49 | 71 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Computational | Neighborhood of CDC20 | 4.95e-04 | 56 | 71 | 4 | GNF2_CDC20 | |
| Computational | Genes in the cancer module 17. | 6.43e-04 | 366 | 71 | 9 | MODULE_17 | |
| Computational | Neighborhood of MKI67 | 8.04e-04 | 28 | 71 | 3 | GNF2_MKI67 | |
| Computational | Genes in the cancer module 198. | 8.27e-04 | 303 | 71 | 8 | MODULE_198 | |
| Computational | Neighborhood of CCNA2 | 1.03e-03 | 68 | 71 | 4 | GNF2_CCNA2 | |
| Computational | Genes in the cancer module 98. | 1.07e-03 | 393 | 71 | 9 | MODULE_98 | |
| Computational | Genes in the cancer module 451. | 1.31e-03 | 33 | 71 | 3 | MODULE_451 | |
| Computational | Neighborhood of SMC2L1 | 1.31e-03 | 33 | 71 | 3 | GNF2_SMC2L1 | |
| Computational | Response to DNA damage. | 1.44e-03 | 187 | 71 | 6 | MODULE_244 | |
| Computational | Genes in the cancer module 8. | 1.72e-03 | 421 | 71 | 9 | MODULE_8 | |
| Computational | Neighborhood of DEK | 1.73e-03 | 264 | 71 | 7 | MORF_DEK | |
| Drug | formate | GNPDA1 GLS2 GART NDUFS1 SLC9A3 SLC9A5 GNPDA2 PGLS PLK1 KPNB1 | 6.72e-07 | 271 | 108 | 10 | CID000000283 |
| Drug | Thapsigargin | MRPL12 CENPF ACLY CKAP5 GEMIN5 HMGCL PPP1R15A AK3 PDIA4 EGFR COQ8A ASPH PGLS RBM5 HSD17B10 CDK1 PLK1 TOP2A ATP5F1A SON CDK7 | 1.31e-06 | 1353 | 108 | 21 | ctd:D019284 |
| Drug | MAPS | 3.64e-06 | 191 | 108 | 8 | CID000066161 | |
| Drug | Dobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 4.41e-06 | 196 | 108 | 8 | 6286_DN | |
| Drug | 1m0o | 6.89e-06 | 56 | 108 | 5 | CID006323413 | |
| Drug | Flavopiridol | 1.22e-05 | 10 | 108 | 3 | DB03496 | |
| Drug | 5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-((2-(trifluoromethyl)benzyl)oxy)thiophene-2-carboxamide | 2.23e-05 | 2 | 108 | 2 | ctd:C524135 | |
| Drug | 5109870; Down 200; 25uM; MCF7; HT_HG-U133A_EA | 2.36e-05 | 179 | 108 | 7 | 904_DN | |
| Drug | Disulfiram [97-77-8]; Down 200; 13.4uM; PC3; HT_HG-U133A | 3.23e-05 | 188 | 108 | 7 | 2053_DN | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; PC3; HT_HG-U133A | 3.57e-05 | 191 | 108 | 7 | 4298_DN | |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; PC3; HG-U133A | 3.70e-05 | 192 | 108 | 7 | 1929_DN | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HG-U133A | 3.70e-05 | 192 | 108 | 7 | 367_DN | |
| Drug | Capsaicin [404-86-4]; Down 200; 13uM; PC3; HT_HG-U133A | 3.95e-05 | 194 | 108 | 7 | 4612_DN | |
| Drug | leukotoxin B (12,13-EODE); Up 200; 0.2uM; MCF7; HT_HG-U133A_EA | 4.08e-05 | 195 | 108 | 7 | 1108_UP | |
| Drug | Cefmetazole sodium salt [56796-39-5]; Down 200; 8.2uM; PC3; HT_HG-U133A | 4.21e-05 | 196 | 108 | 7 | 5868_DN | |
| Drug | Promethazine hydrochloride [58-33-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 4.35e-05 | 197 | 108 | 7 | 5317_UP | |
| Drug | Pronethalol hydrochloride [51-02-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 108 | 7 | 7322_UP | |
| Drug | Bethanechol chloride [590-63-6]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 108 | 7 | 3537_UP | |
| Disease | reticulocyte count | CNNM2 GLS2 ACLY GEMIN5 HMGCL RFC1 PPP1R15A THADA SLC9A5 TMEM267 MAP4K5 DDX39A TNS1 DDX39B | 1.84e-05 | 1045 | 104 | 14 | EFO_0007986 |
| Disease | acetate measurement | 4.64e-05 | 20 | 104 | 3 | EFO_0010112 | |
| Disease | obstructive sleep apnea | 8.87e-05 | 66 | 104 | 4 | EFO_0003918 | |
| Disease | nephrolithiasis (implicated_via_orthology) | 1.22e-04 | 5 | 104 | 2 | DOID:585 (implicated_via_orthology) | |
| Disease | neutrophil count, basophil count | 1.46e-04 | 224 | 104 | 6 | EFO_0004833, EFO_0005090 | |
| Disease | periventricular nodular heterotopia (is_implicated_in) | 1.83e-04 | 6 | 104 | 2 | DOID:0050454 (is_implicated_in) | |
| Disease | Squamous cell carcinoma of lung | 1.96e-04 | 32 | 104 | 3 | C0149782 | |
| Disease | Periventricular Nodular Heterotopia | 2.55e-04 | 7 | 104 | 2 | C1868720 | |
| Disease | serine measurement | 2.56e-04 | 35 | 104 | 3 | EFO_0009774 | |
| Disease | reticulocyte measurement | CNNM2 GLS2 RFC1 PPP1R15A PACS1 BCL11B SLC9A5 TMEM267 MAP4K5 DDX39A TNS1 DDX39B | 3.39e-04 | 1053 | 104 | 12 | EFO_0010700 |
| Disease | Head and Neck Carcinoma | 5.44e-04 | 10 | 104 | 2 | C3887461 | |
| Disease | 3-aminoisobutyrate measurement | 7.94e-04 | 12 | 104 | 2 | EFO_0010980 | |
| Disease | Adenocarcinoma of lung (disorder) | 8.30e-04 | 206 | 104 | 5 | C0152013 | |
| Disease | neutrophil count, eosinophil count | 9.64e-04 | 213 | 104 | 5 | EFO_0004833, EFO_0004842 | |
| Disease | factor VII measurement | 9.77e-04 | 55 | 104 | 3 | EFO_0004619 | |
| Disease | isoleucine measurement | 1.03e-03 | 56 | 104 | 3 | EFO_0009793 | |
| Disease | glucose homeostasis measurement, glucose effectiveness measurement | 1.25e-03 | 15 | 104 | 2 | EFO_0006833, EFO_0006896 | |
| Disease | Malignant neoplasm of breast | CENPF NOA1 LAMA2 TTC3 SHROOM2 FSCB CSF1R EGFR MRPS23 TNS1 TOP2A | 1.44e-03 | 1074 | 104 | 11 | C0006142 |
| Disease | uric acid measurement | 1.44e-03 | 610 | 104 | 8 | EFO_0004761 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 1.45e-03 | 63 | 104 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | protein C measurement | 1.62e-03 | 17 | 104 | 2 | EFO_0004633 | |
| Disease | histidine measurement | 1.66e-03 | 66 | 104 | 3 | EFO_0009769 | |
| Disease | Adrenocortical carcinoma | 1.81e-03 | 18 | 104 | 2 | C0206686 | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 2.02e-03 | 19 | 104 | 2 | DOID:2876 (is_marker_for) | |
| Disease | renovascular hypertension (biomarker_via_orthology) | 2.02e-03 | 19 | 104 | 2 | DOID:1591 (biomarker_via_orthology) | |
| Disease | granulocyte count | 2.09e-03 | 254 | 104 | 5 | EFO_0007987 | |
| Disease | granulocyte percentage of myeloid white cells | 2.64e-03 | 268 | 104 | 5 | EFO_0007997 | |
| Disease | cholangiocarcinoma (is_implicated_in) | 2.71e-03 | 22 | 104 | 2 | DOID:4947 (is_implicated_in) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.87e-03 | 80 | 104 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | level of Phosphatidylinositol (18:0_20:4) in blood serum | 2.97e-03 | 23 | 104 | 2 | OBA_2045158 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DELVGKTAAAGKVVV | 1391 | Q5RHP9 | |
| DIKGEAAFAFIVVKD | 586 | Q9NUB1 | |
| KEIVVKGDEVIFGEF | 16 | Q6P1J9 | |
| AAVKGLGKEDAALSI | 1306 | Q8WWZ4 | |
| FVATGEGKAAVLKRI | 201 | O95336 | |
| AVFFGGLSIKKDEEV | 146 | Q13838 | |
| VFFGGLSIKKDEEVL | 146 | O00148 | |
| KALEKAGGKEFLETV | 231 | Q9P0M6 | |
| KKLGLVFDDVVGIVE | 376 | Q01518 | |
| FDGKIVIDGIDISKL | 1366 | O60706 | |
| GEVVKAFVVLAAPFK | 511 | P0C7M7 | |
| GDFDVDDAKVLLGLK | 96 | Q12797 | |
| AIVEKVLIFGGDILK | 81 | Q96PN6 | |
| KGVVEKSLGLAAADL | 311 | O94850 | |
| EGKVKLALLLAAVGA | 36 | Q9BXT2 | |
| VVVFGNDKLIKEGDI | 116 | P25705 | |
| ELAFKAGDVIKVLDA | 26 | O43307 | |
| GADELGLRKAVKAEF | 121 | Q9HCE9 | |
| AEIFAELGEVIKGVK | 266 | Q14894 | |
| AEKLFGELFKIGAKI | 1001 | Q15032 | |
| LGLGLKEKEEAVVAA | 241 | Q9BTD8 | |
| HLFKVLVVGDAAVGK | 6 | O14966 | |
| ALDGDKAFLEKLGVS | 241 | Q6ZRP7 | |
| IFILAAVDTAEAGKK | 21 | P21246 | |
| ANVAKDLGLEVGKLA | 46 | Q9Y5F3 | |
| KKGAAFELVFIVLAE | 96 | P56470 | |
| GKIFQAAKDAGIALL | 641 | P33897 | |
| KLACGDDVLVVAKGV | 186 | Q8NGA6 | |
| KKEGKAAEAVAAAVG | 786 | P46821 | |
| FEEKIKAAGGIELFV | 121 | P46926 | |
| VKLGSVVLEGEAKFE | 771 | Q5H9T9 | |
| EIGVLAKAFIDQGKL | 51 | Q9UIJ7 | |
| KVFFKAGLLGVLEEL | 811 | A7E2Y1 | |
| RIFEDVKELTGGKVA | 166 | Q9UI32 | |
| KAVGGFKVGLDLLVE | 2951 | P24043 | |
| KAGAKDILVATDVAG | 711 | Q9BUQ8 | |
| DLFKGAKEHGAVAVE | 121 | Q9UNZ2 | |
| AGFALFEKKGALAER | 581 | P52756 | |
| ALAKGKFGRVDVAVN | 76 | Q99714 | |
| ALLKRFKVSDEVGFG | 336 | Q6VY07 | |
| VKITDFGLAKLLGAE | 851 | P00533 | |
| EALGTALKVVGEKAV | 461 | Q14008 | |
| AFGLGKEDAVLKVAV | 601 | P07333 | |
| GSLLGEKAQIAAAKE | 366 | Q9P2D3 | |
| GGAAKALADEKALVL | 581 | Q9C0K0 | |
| KALEAALVEKGEFAL | 2091 | P49454 | |
| ILKFGAEDLFKELEG | 971 | O14647 | |
| DENGVLKLADFGLAK | 146 | P50613 | |
| AVGLGFGALAEVAKK | 221 | Q8NI60 | |
| GKTIKLADAGEALTF | 231 | Q8NFQ5 | |
| AVALGVEGEAKAILA | 281 | Q5I0G3 | |
| VFGDIALAIGGEFKK | 716 | Q14974 | |
| FENKIKEAGGIDLFV | 121 | Q8TDQ7 | |
| SGEEIFRKKAVELGV | 296 | P33908 | |
| AGLKKEVQALIAEGI | 806 | Q14204 | |
| GDVVFVSKDVAKHLG | 186 | P50053 | |
| IGKEKVFLAIADVLG | 881 | Q6PJP8 | |
| VLRDKFGDAVKGNLV | 546 | Q9UHW9 | |
| KEGLGASEAVADIKF | 611 | Q8NC60 | |
| AIVSEKGEVKGFLRV | 871 | Q12756 | |
| HGDVKLADFGVAAKI | 151 | Q9Y4K4 | |
| LVEAVKGAALVEAGL | 46 | O75807 | |
| KLACGDDVLVVAKGV | 186 | Q9Y4A9 | |
| EVVFKCLGEGILEKA | 76 | Q9H1H9 | |
| KLFVETGKALLAEGV | 116 | Q9Y3D9 | |
| DELAKLDAFVEGVVK | 56 | P21283 | |
| EKFLAAASGLGEKGV | 1566 | Q6YHU6 | |
| LAKILEGSGVDAKVE | 101 | Q9Y4C2 | |
| ATFGLEDDVVKKGAI | 166 | Q9HB63 | |
| IAGGLVDAEALVALK | 341 | P28331 | |
| KAAALGTKIIDEDGL | 461 | P35251 | |
| KGFEAAVAAGAKEVV | 111 | P35914 | |
| EKAKVEVGVATALGI | 131 | Q9UL19 | |
| GAVAFALVVLLDGDK | 416 | P48764 | |
| KAAAVDKLLAGDEIV | 61 | Q13796 | |
| ALAVGVGAKVAFSKA | 196 | A6NL88 | |
| VLGGIVLAVAKKAEY | 86 | Q14940 | |
| KGVDGFSLDAVKFLL | 306 | Q07837 | |
| KDGDDVIIIGVFKGE | 301 | P13667 | |
| AGVEAKGLSIRFKVV | 186 | Q96PL2 | |
| FVEALKTEFAGKGLR | 166 | Q92871 | |
| AEKIKAALEAVGGTV | 181 | P52815 | |
| DVGDVDAKAQKLLVG | 141 | P53396 | |
| IDDKGTIKLADFGLA | 136 | P06493 | |
| FVLILQGKVEVEAGK | 686 | Q9H8M5 | |
| GAGAVIIASEDAVKK | 256 | P42765 | |
| SELKVAEVKEGALLG | 251 | Q8IZ63 | |
| VAGLEGAKEALKEAV | 136 | O75351 | |
| LGVVFGKEDLDDAFK | 276 | Q9HBL0 | |
| VKDLIVSGDEKGVVF | 121 | Q8TEQ6 | |
| AIASLKGFAGLDKAV | 516 | Q9C0B7 | |
| DLAKKVANDSFLIGG | 136 | P53804 | |
| EVGKKIFAINGDLVF | 631 | Q70Z35 | |
| ANVAHKKIELFVGGE | 926 | O00507 | |
| FEKAIGDVIAAKGDR | 236 | Q6PF05 | |
| EEAKKGLAAIKFEGA | 401 | P22102 | |
| GVELEFSGLDIKFKD | 86 | Q9HD45 | |
| EKFIKAAIGCGIVES | 396 | P11388 | |
| FGLKGLVKAEDKARV | 441 | Q96KM6 | |
| DLAAAGKKLGISFLE | 106 | Q8NAP3 | |
| FKAGKALVISGREVF | 281 | Q8WU90 | |
| KEKLLFAIEETEGFG | 906 | Q9H0M0 | |
| LVDFKTDRKGLVAVG | 2336 | P18583 | |
| IKKKTDFGEIILAGF | 71 | Q0VDI3 | |
| IAKKIEIGDGAELTA | 291 | Q6IBS0 | |
| GLEGAKEALKEAVIL | 131 | Q9UN37 | |
| EDLEVKIGDFGLATK | 186 | P53350 | |
| VVSGIDLAKKDIFGA | 26 | Q96PU5 |